BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440. [PMID: 8153634 DOI: 10.1126/science.8153634] [Cited by in Crossref: 1862] [Cited by in F6Publishing: 1727] [Article Influence: 66.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Dermatakis A, Lukacs C, Konzelmann F, Chen Y, Kammlott U, Depinto W, Yang H, Yin X, Chen Y, Schutt A, Simcox ME, Luk K. 3,5,6-Trisubstituted naphthostyrils as CDK2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2003;13:2465-8. [DOI: 10.1016/s0960-894x(03)00488-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
2 Lü XC, Montelius-alatalo K, Helou K, Klinga-levan K, Islam Q, Levan G, Röhme D. Isolation of DNA markers for the ratSai 1 gene for suppression of anchorage independence by using representational difference analysis. Somat Cell Mol Genet 1997;23:63-74. [DOI: 10.1007/bf02679956] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Lin YX, Baladandayuthapani V, Bonato V, Do KA. Estimating Shared Copy Number Aberrations for Array CGH Data: The Linear-Median Method. Cancer Inform 2010;9:229-49. [PMID: 21082039 DOI: 10.4137/CIN.S5614] [Reference Citation Analysis]
4 Wolf JK, Kim T, Fightmaster D, Bodurka D, Gershenson DM, Mills G, Wharton J. Growth Suppression of Human Ovarian Cancer Cell Lines by the Introduction of a p16 Gene via a Recombinant Adenovirus. Gynecologic Oncology 1999;73:27-34. [DOI: 10.1006/gyno.1998.5259] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
5 Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer: PROGNOSTIC FACTORS IN GASTRIC CANCER. Br J Surg 1997;84:1651-64. [DOI: 10.1046/j.1365-2168.1997.00619.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Keller-melchior R, Schmidt R, Piepkorn M. Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic Lesions. Journal of Investigative Dermatology 1998;110:932-8. [DOI: 10.1046/j.1523-1747.1998.00211.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
7 Tringler B, Grimm C, Dudek G, Zeillinger R, Tempfer C, Speiser P, Joura E, Reinthaller A, Hefler LA. p16INK4a Expression in Invasive Vulvar Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2007;15:279-83. [DOI: 10.1097/01.pai.0000213118.81343.32] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
8 Griewank KG, Scolyer RA, Thompson JF, Flaherty KT, Schadendorf D, Murali R. Genetic alterations and personalized medicine in melanoma: progress and future prospects. J Natl Cancer Inst 2014;106:djt435. [PMID: 24511108 DOI: 10.1093/jnci/djt435] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
9 Saegusa M, Okayasu I. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas. Br J Cancer 1999;80:51-8. [PMID: 10389977 DOI: 10.1038/sj.bjc.6690320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
10 Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001;11:255-263. [PMID: 11468514 DOI: 10.1097/00008390-200106000-00007] [Cited by in Crossref: 109] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
11 Delmonico L, Moreira Ados S, Franco MF, Esteves EB, Scherrer L, Gallo CV, do Nascimento CM, Ornellas MH, de Azevedo CM, Alves G. CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable breast lesions. Hum Pathol 2015;46:1540-7. [PMID: 26255234 DOI: 10.1016/j.humpath.2015.06.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
12 Yue H, Na YL, Feng XL, Ma SR, Song FL, Yang B. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol 2003; 9(2): 377-380 [PMID: 12532471 DOI: 10.3748/wjg.v9.i2.377] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
13 Okami K, Cairns P, Westra WH, Linn JF, Ahrendt SA, Wu L, Sidransky D, Jen J. Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int J Cancer 1997;74:588-92. [PMID: 9421353 DOI: 10.1002/(sici)1097-0215(19971219)74:6<588::aid-ijc5>3.0.co;2-q] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
14 Bardeesy N, Morgan J, Sinha M, Signoretti S, Srivastava S, Loda M, Merlino G, DePinho RA. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol 2002;22:635-43. [PMID: 11756558 DOI: 10.1128/MCB.22.2.635-643.2002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
15 Anayama T, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 1998;79:439-43. [PMID: 9699540 DOI: 10.1002/(sici)1097-0215(19980821)79:4<439::aid-ijc22>3.0.co;2-z] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jung I, Messing E. Molecular Mechanisms and Pathways in Bladder Cancer Development and Progression. Cancer Control 2000;7:325-34. [DOI: 10.1177/107327480000700401] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
17 Lee JJ, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY. Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR. Korean J Pathol 2012;46:554-61. [PMID: 23323106 DOI: 10.4132/KoreanJPathol.2012.46.6.554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
18 Nataraj AJ, Trent JC 2nd, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem Photobiol 1995;62:218-30. [PMID: 7480131 DOI: 10.1111/j.1751-1097.1995.tb05262.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 3.9] [Reference Citation Analysis]
19 Raffel C, Ueki K, Harsh GR, Louis DN. The Multiple Tumor Suppressor 1/Cyclin-dependent Kinase Inhibitor 2 Gene in Human Central Nervous System Primitive Neuroectodermal Tumor. Neurosurgery 1995;36:971-5. [DOI: 10.1227/00006123-199505000-00013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
20 Guan RJ, Fu Y, Holt PR, Pardee AB. Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology. 1999;116:1063-1071. [PMID: 10220498 DOI: 10.1016/s0016-5085(99)70009-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
21 Reimers N, Kasper HU, Weissenborn SJ, Stützer H, Preuss SF, Hoffmann TK, Speel EJ, Dienes HP, Pfister HJ, Guntinas-Lichius O. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731-1738. [PMID: 17236202 DOI: 10.1002/ijc.22355] [Cited by in Crossref: 323] [Cited by in F6Publishing: 299] [Article Influence: 21.5] [Reference Citation Analysis]
22 Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 2002;55:669-75. [PMID: 12194996 DOI: 10.1136/jcp.55.9.669] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 2.8] [Reference Citation Analysis]
23 Mohamed H, Hagström J, Jouhi L, Atula T, Almangush A, Mäkitie A, Haglund C. The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma. Tumour Biol 2019;41:1010428319840473. [PMID: 30915904 DOI: 10.1177/1010428319840473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Cheng L, Williamson SR, Zhang S, Maclennan GT, Montironi R, Lopez-beltran A. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Review of Anticancer Therapy 2014;10:843-64. [DOI: 10.1586/era.10.72] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
25 Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin W, Pour PM, Song H, Gold B, Batra SK, Weghorst CM. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16INK4a and p15INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Gene 2001;278:235-43. [DOI: 10.1016/s0378-1119(01)00728-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Giordano A, Rossi A, Romano G, Bagella L. Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy. J Cell Physiol. 2007;213:403-406. [PMID: 17708530 DOI: 10.1002/jcp.21225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
27 Vesely J, Havlicek L, Strnad M, Blow JJ, Donella-deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, Meijer L. Inhibition of Cyclin-Dependent Kinases by Purine Analogues. Eur J Biochem 1994;224:771-86. [DOI: 10.1111/j.1432-1033.1994.00771.x] [Cited by in Crossref: 440] [Cited by in F6Publishing: 443] [Article Influence: 15.7] [Reference Citation Analysis]
28 Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia. Blood 1998;91:3995-4019. [DOI: 10.1182/blood.v91.11.3995.411a43_3995_4019] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
29 Gjerset RA. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer. J Mol Histol 2006;37:239-51. [PMID: 16855788 DOI: 10.1007/s10735-006-9040-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
30 Chen YZ, Soeda E, Yang HW, Takita J, Chai L, Horii A, Inazawa J, Ohki M, Hayashi Y. Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36. Genes Chromosom Cancer 2001;31:326-32. [DOI: 10.1002/gcc.1151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
31 Wu T, Wu L. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Front Oncol 2021;11:655630. [PMID: 34136392 DOI: 10.3389/fonc.2021.655630] [Reference Citation Analysis]
32 Lu Y, Boswell M, Boswell W, Kneitz S, Hausmann M, Klotz B, Regneri J, Savage M, Amores A, Postlethwait J, Warren W, Schartl M, Walter R. Molecular genetic analysis of the melanoma regulatory locus in Xiphophorus interspecies hybrids. Mol Carcinog 2017;56:1935-44. [PMID: 28345808 DOI: 10.1002/mc.22651] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Bodner K, Laubichler P, Kimberger O, Czerwenka K, Zeillinger R, Bodner-Adler B. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis. Arch Gynecol Obstet 2011;283:611-6. [PMID: 20405295 DOI: 10.1007/s00404-010-1464-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
34 Gong Y, Zack TI, Morris LG, Lin K, Hukkelhoven E, Raheja R, Tan IL, Turcan S, Veeriah S, Meng S, Viale A, Schumacher SE, Palmedo P, Beroukhim R, Chan TA. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nat Genet 2014;46:588-94. [PMID: 24793136 DOI: 10.1038/ng.2981] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 13.8] [Reference Citation Analysis]
35 Izumoto S, Arita N, Ohnishi T, Hiraga S, Taki T, Hayakawa T. Homozygous deletions of p16INK4A/MTS1 and p15INK4B/MTS2 genes in glioma cells and primary glioma tissues. Cancer Letters 1995;97:241-7. [DOI: 10.1016/0304-3835(95)03981-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
36 Lukas J, Bartkova J, Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 1996;16:6917-25. [PMID: 8943347 DOI: 10.1128/MCB.16.12.6917] [Cited by in Crossref: 224] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
37 Kiwerska K, Rydzanicz M, Kram A, Pastok M, Antkowiak A, Domagała W, Szyfter K. Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients. Mol Biol Rep 2010;37:325-32. [DOI: 10.1007/s11033-009-9731-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
38 Toren A, Amariglio N, Rechavi G. Curable and noncurable malignancies:Lessons from paediatric cancer. Med Oncol 1996;13:15-21. [DOI: 10.1007/bf02988837] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Lees E. Cyclin dependent kinase regulation. Current Opinion in Cell Biology 1995;7:773-80. [DOI: 10.1016/0955-0674(95)80060-3] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 7.1] [Reference Citation Analysis]
40 Platz A, Sevigny P, Norberg T, Ring P, Lagerlöf B, Ringborg U. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996;74:936-41. [PMID: 8826861 DOI: 10.1038/bjc.1996.460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
41 Lu J, Wood D, Ingley E, Koks S, Wong D. Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma. Mol Biol Rep 2021;48:3637-47. [PMID: 33893924 DOI: 10.1007/s11033-021-06362-5] [Reference Citation Analysis]
42 Wong H, Riabowol K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Experimental Gerontology 1996;31:311-25. [DOI: 10.1016/0531-5565(95)00025-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 2.7] [Reference Citation Analysis]
43 Kadariya Y, Nishioka J, Nakatani K, Nakashima K, Nobori T. Deletion of dinucleotide repeat (Delta 14 allele) in the methylthioadenosine phosphorylase (MTAP) promoter and the allelotype of MTAP promoter in the Japanese population. Jpn J Cancer Res 2002;93:369-73. [PMID: 11985785 DOI: 10.1111/j.1349-7006.2002.tb01266.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Bressac-de-paillerets B, Avril M, Chompret A, Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie 2002;84:67-74. [DOI: 10.1016/s0300-9084(01)01360-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
45 Fernández-piqueras J, Santos J, Pérez de Castro I, Meléndez B, Martínez B, Robledo M, Rivas C, Benítez J. Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage. Cancer Genetics and Cytogenetics 1997;98:63-8. [DOI: 10.1016/s0165-4608(96)00400-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
46 Lumniczky K, Antal S, Unger E, Wunderlich L, Hidvégi EJ, Sáfrány G. Carcinogenic alterations in murine liver, lung, and uterine tumors induced by in utero exposure to ionizing radiation. Mol Carcinog 1998;21:100-10. [DOI: 10.1002/(sici)1098-2744(199802)21:2<100::aid-mc4>3.0.co;2-r] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
47 Weir B, Zhao X, Meyerson M. Somatic alterations in the human cancer genome. Cancer Cell 2004;6:433-8. [PMID: 15542426 DOI: 10.1016/j.ccr.2004.11.004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 5.9] [Reference Citation Analysis]
48 Herman JG. Hypermethylation of tumor suppressor genes in cancer. Seminars in Cancer Biology 1999;9:359-67. [DOI: 10.1006/scbi.1999.0138] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 5.5] [Reference Citation Analysis]
49 Murray AW. Cyclin-dependent kinases: regulators of the cell cycle and more. Chem Biol 1994;1:191-5. [PMID: 9383389 DOI: 10.1016/1074-5521(94)90009-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
50 Saab J, Santos-Zabala ML, Loda M, Stack EC, Hollmann TJ. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi. Am J Dermatopathol 2018;40:259-64. [PMID: 28654463 DOI: 10.1097/DAD.0000000000000939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
51 Brown MA. Tumor suppressor genes and human cancer. Adv Genet. 1997;36:45-135. [PMID: 9348653 DOI: 10.1016/s0065-2660(08)60307-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
52 Warnakulasuriya KAAS, Tavassoli M, Johnson NW. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 1998;27:376-81. [DOI: 10.1111/j.1600-0714.1998.tb01970.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
53 Rosaria De Vitis L, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bono P, Grammatico B, Grammatico P, Radice P, Bigozzi U, Montali E, Papi L. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. Hum Genet 1996;97:638-41. [DOI: 10.1007/bf02281875] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
54 De Luca A, Maclachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity. Journal of Biological Chemistry 1997;272:20971-4. [DOI: 10.1074/jbc.272.34.20971] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 2.0] [Reference Citation Analysis]
55 Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M, Saito I. Exogenous expression of p16INK4a is associated with decrease in telomerase activity. J Neurooncol 1999;42:45-57. [PMID: 10360478 DOI: 10.1023/a:1006176708928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
56 Pisick E, Salgia R. Molecular biology of malignant mesothelioma: a review. Hematol Oncol Clin North Am 2005;19:997-1023, v. [PMID: 16325120 DOI: 10.1016/j.hoc.2005.09.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
57 Jang S, Atkins MB. Treatment of BRAF-mutant melanoma: the role of vemurafenib and other therapies. Clin Pharmacol Ther 2014;95:24-31. [PMID: 24080641 DOI: 10.1038/clpt.2013.197] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
58 Chanock S, Yeager M. The future of pediatric cancer and complex diseases: Aren't they all? Pediatr Blood Cancer 2007;48:719-22. [DOI: 10.1002/pbc.21115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochem Biophys Res Commun 1998;247:146-53. [PMID: 9636670 DOI: 10.1006/bbrc.1998.8497] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
60 Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Cancer Genet Cytogenet 2005;158:172-9. [PMID: 15796965 DOI: 10.1016/j.cancergencyto.2004.08.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
61 Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet. 1999;21:163-167. [PMID: 9988266 DOI: 10.1038/5947] [Cited by in Crossref: 1525] [Cited by in F6Publishing: 1426] [Article Influence: 66.3] [Reference Citation Analysis]
62 Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003;163:477-91. [PMID: 12875969 DOI: 10.1016/s0002-9440(10)63677-2] [Cited by in Crossref: 79] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
63 Miele ME, Robertson G, Lee J, Coleman A, Mcgary CT, Fisher PB, Lugo TG, Welch DR. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Mol Carcinog 1996;15:284-99. [DOI: 10.1002/(sici)1098-2744(199604)15:4<284::aid-mc6>3.0.co;2-g] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
64 Sheikh BN, Phipson B, El-saafin F, Vanyai HK, Downer NL, Bird MJ, Kueh AJ, May RE, Smyth GK, Voss AK, Thomas T. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway. Oncogene 2015;34:5807-20. [DOI: 10.1038/onc.2015.33] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
65 Wang S, Tian C, Xing G, Gao M, Jiao W, Xiao T, Yin Y, He F, Zhang L. ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress. FEBS Lett 2010;584:3909-15. [PMID: 20713054 DOI: 10.1016/j.febslet.2010.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
66 Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994;78:67-74. [PMID: 8033213 DOI: 10.1016/0092-8674(94)90573-8] [Cited by in Crossref: 1395] [Cited by in F6Publishing: 1399] [Article Influence: 49.8] [Reference Citation Analysis]
67 Ji Z, Njauw CN, Taylor M, Neel V, Flaherty KT, Tsao H. p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition. J Invest Dermatol 2012;132:356-64. [PMID: 21993556 DOI: 10.1038/jid.2011.313] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
68 Stuart ET, Yokota Y, Gruss P. 8 PAX and HOX in Neoplasia. Elsevier; 1995. pp. 255-74. [DOI: 10.1016/s0065-2660(08)60336-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Bernards R. CDK-independent activities of D type cyclins. Biochim Biophys Acta 1999;1424:M17-22. [PMID: 10528151 DOI: 10.1016/s0304-419x(99)00024-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis]
70 Healy E, Rehman I, Angus B, Rees JL. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosom Cancer 1995;12:152-6. [DOI: 10.1002/gcc.2870120211] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 2.7] [Reference Citation Analysis]
71 Sherr CJ, Sicinski P. The D-Type Cyclins: A Historical Perspective. In: Hinds PW, Brown NE, editors. D-type Cyclins and Cancer. Cham: Springer International Publishing; 2018. pp. 1-26. [DOI: 10.1007/978-3-319-64451-6_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Jiang H, Wortsman J, Matsuoka L, Granese J, Carlson JA, Mihm M, Slominski A. Molecular spectrum of pigmented skin lesions: from nevus to melanoma. Expert Review of Dermatology 2014;1:679-700. [DOI: 10.1586/17469872.1.5.679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Park NI, Rogan PK, Tarnowski HE, Knoll JH. Structural and genic characterization of stable genomic regions in breast cancer: relevance to chemotherapy. Mol Oncol 2012;6:347-59. [PMID: 22342187 DOI: 10.1016/j.molonc.2012.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
74 Wilkinson D, Sandhu JK, Breneman JW, Tucker JD, Birnboim HC. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br J Cancer 1995;72:1234-40. [PMID: 7577474 DOI: 10.1038/bjc.1995.492] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
75 Herman JG. Hypermethylation pathways to colorectal cancer. Gastroenterology Clinics of North America 2002;31:945-58. [DOI: 10.1016/s0889-8553(02)00058-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486-541. [PMID: 29362479 DOI: 10.1038/s41418-017-0012-4] [Cited by in Crossref: 1577] [Cited by in F6Publishing: 1520] [Article Influence: 394.3] [Reference Citation Analysis]
77 Vaziri C, Faller DV. Down-regulation of Platelet-derived Growth Factor Receptor Expression during Terminal Differentiation of 3T3-L1 Pre-adipocyte Fibroblasts. Journal of Biological Chemistry 1996;271:13642-8. [DOI: 10.1074/jbc.271.23.13642] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
78 Akao T, Kakehi Y, Itoh N, Ozdemir E, Shimizu T, Tachibana A, Sasaki MS, Yoshida O. A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers. Jpn J Cancer Res 1997;88:1078-86. [PMID: 9439683 DOI: 10.1111/j.1349-7006.1997.tb00332.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
79 Hameetman L, Szuhai K, Yavas A, Knijnenburg J, van Duin M, van Dekken H, Taminiau AH, Cleton-Jansen AM, Bovée JV, Hogendoorn PC. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 2007;99:396-406. [PMID: 17341731 DOI: 10.1093/jnci/djk067] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
80 Park MT, Lee SJ. Cell cycle and cancer. J Biochem Mol Biol. 2003;36:60-65. [PMID: 12542976 DOI: 10.5483/BMBRep.2003.36.1.060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 3.0] [Reference Citation Analysis]
81 Elenitoba-johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M. Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma. Blood 1998;91:4677-85. [DOI: 10.1182/blood.v91.12.4677] [Cited by in Crossref: 139] [Article Influence: 5.8] [Reference Citation Analysis]
82 González MV, Artímez ML, Rodrigo L, López-Larrea C, Menéndez MJ, Alvarez V, Pérez R, Fresno MF, Pérez MJ, Sampedro A, Coto E. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 1997;50:212-7. [PMID: 9155671 DOI: 10.1136/jcp.50.3.212] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 2.8] [Reference Citation Analysis]
83 Ordulu Z, Nucci MR, Dal Cin P, Hollowell ML, Otis CN, Hornick JL, Park PJ, Kim TM, Quade BJ, Morton CC. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol 2016;29:500-10. [PMID: 26892441 DOI: 10.1038/modpathol.2016.36] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
84 Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosom Cancer 1999;26:171-5. [DOI: 10.1002/(sici)1098-2264(199910)26:2<171::aid-gcc10>3.0.co;2-b] [Cited by in Crossref: 24] [Article Influence: 1.0] [Reference Citation Analysis]
85 Medema RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A 1995;92:6289-93. [PMID: 7603984 DOI: 10.1073/pnas.92.14.6289] [Cited by in Crossref: 267] [Cited by in F6Publishing: 290] [Article Influence: 9.9] [Reference Citation Analysis]
86 Böhm M, Kirch H, Otto T, Rübben H, Wieland I. Deletion analysis at theDEL-27,APC andMTS1 loci in bladder cancer: LOH at theDEL-27 locus on 5p13-12 is a prognostic marker of tumor progression. Int J Cancer 1997;74:291-5. [DOI: 10.1002/(sici)1097-0215(19970620)74:3<291::aid-ijc10>3.0.co;2-f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
87 Bito T, Ueda M, Ahmed NU, Nagano T, Ichihashi M. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Cutan Pathol 1995;22:427-34. [DOI: 10.1111/j.1600-0560.1995.tb00758.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
88 Conway C, Beswick S, Elliott F, Chang YM, Randerson-Moor J, Harland M, Affleck P, Marsden J, Sanders DS, Boon A, Knowles MA, Bishop DT, Newton-Bishop JA. Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma. Genes Chromosomes Cancer 2010;49:425-38. [PMID: 20140953 DOI: 10.1002/gcc.20753] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
89 Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 2017;14:463-82. [PMID: 28374786 DOI: 10.1038/nrclinonc.2017.43] [Cited by in Crossref: 528] [Cited by in F6Publishing: 497] [Article Influence: 105.6] [Reference Citation Analysis]
90 Bhagat R, Kumar SS, Vaderhobli S, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma. Tumour Biol 2014;35:9069-78. [PMID: 24913706 DOI: 10.1007/s13277-014-2136-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
91 Kudo Y, Kitajima S, Ogawa I, Miyauchi M, Takata T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol. 2005;41:105-116. [PMID: 15695111 DOI: 10.1016/j.oraloncology.2004.05.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
92 Zhu G, Conner SE, Zhou X, Chan H, Shih C, Engler TA, Al-awar RS, Brooks HB, Watkins SA, Spencer CD, Schultz RM, Dempsey JA, Considine EL, Patel BR, Ogg CA, Vasudevan V, Lytle ML. Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 2004;14:3057-61. [DOI: 10.1016/j.bmcl.2004.04.033] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
93 Sherr CJ. Parsing Ink4a/Arf. Cell 2001;106:531-4. [DOI: 10.1016/s0092-8674(01)00486-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
94 Goretzki PE, Gorelov V, Dotzenrath C, Witte J, Roeher H. A frequent mutation/polymorphism in tumor suppressor gene INK4B (MTS-2) in papillary and medullary thyroid cancer. Surgery 1996;120:1081-8. [DOI: 10.1016/s0039-6060(96)80059-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
95 Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-feldhaus J, Kamb A, Bergman W, Frants RR. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995;10:351-3. [DOI: 10.1038/ng0795-351] [Cited by in Crossref: 205] [Cited by in F6Publishing: 183] [Article Influence: 7.6] [Reference Citation Analysis]
96 Wu J, Zheng W, Rong L, Xing Y, Hu D. Bicyclol exerts an anti-tumor effect via ROS-mediated endoplasmic reticulum stress in human renal cell carcinoma cells. Biomed Pharmacother 2017;91:1184-92. [PMID: 28535587 DOI: 10.1016/j.biopha.2017.05.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Greene MH. Genetics of Cutaneous Melanoma and Nevi. Mayo Clinic Proceedings 1997;72:467-74. [DOI: 10.4065/72.5.467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
98 Hansson A, Manetopoulos C, Jönsson JI, Axelson H. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes. Biochem Biophys Res Commun 2003;312:1073-81. [PMID: 14651981 DOI: 10.1016/j.bbrc.2003.11.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
99 Nagase H, Bryson S, Fee F, Balmain A. Multigenic Control of Skin Tumour Development in Mice. In: Chadwick D, Cardew G, editors. Ciba Foundation Symposium 197 - Variation in the Human Genome. Chichester: John Wiley & Sons, Ltd.; 2007. pp. 156-80. [DOI: 10.1002/9780470514887.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
100 Schröder M, Mathieu U, Dreyling MH, Bohlander SK, Hagemeijer A, Beverloo BH, Olopade OI, Stilgenbauer S, Fischer K, Bentz M, Lichter P, Döhner H. CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia. Br J Haematol 1995;91:865-70. [DOI: 10.1111/j.1365-2141.1995.tb05402.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
101 Goldsmith EJ, Cobb MH. Protein kinases. Current Opinion in Structural Biology 1994;4:833-40. [DOI: 10.1016/0959-440x(94)90264-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
102 Kamb A. Cell-cycle regulators and cancer. Trends Genet. 1995;11:136-140. [PMID: 7732591 DOI: 10.1016/s0168-9525(00)89027-7] [Cited by in Crossref: 188] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
103 Huang Y, Peters CJ, Fitzgerald RC, Gjerset RA. Progressive silencing of p14ARF in oesophageal adenocarcinoma. J Cell Mol Med 2009;13:398-409. [PMID: 18410530 DOI: 10.1111/j.1582-4934.2008.00336.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
104 Kugoh H, Nakamoto H, Inoue J, Funaki K, Barrett JC, Oshimura M. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer. Mol Carcinog 2002;35:148-56. [PMID: 12410566 DOI: 10.1002/mc.10080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
105 Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y. Isolation and mutational analysis of a novel human cDNA,DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosom Cancer 2000;27:169-76. [DOI: 10.1002/(sici)1098-2264(200002)27:2<169::aid-gcc8>3.0.co;2-m] [Cited by in Crossref: 31] [Article Influence: 1.4] [Reference Citation Analysis]
106 Maurer CC, Syrigos KN. Biology of Tobacco and Smoking. In: Syrigos KN, Nutting CM, Roussos C, editors. Tumors of the Chest. Springer Berlin Heidelberg; 2006. pp. 23-39. [DOI: 10.1007/3-540-31040-1_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Gonzalez-Vasconcellos I, Domke T, Kuosaite V, Esposito I, Sanli-Bonazzi B, Nathrath M, Atkinson MJ, Rosemann M. Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in alpha-particle irradiated mice. Radiat Environ Biophys 2011;50:135-41. [PMID: 21063720 DOI: 10.1007/s00411-010-0339-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
108 Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Broxson A, Khuri FR, Hong WK, Lee JJ, Yu R, Ro JY, Kemp BL, Morice RC, Walsh GL, Hittelman WN. Clonal Genetic Alterations in the Lungs of Current and Former Smokers. JNCI Journal of the National Cancer Institute 1997;89:857-62. [DOI: 10.1093/jnci/89.12.857] [Cited by in Crossref: 296] [Cited by in F6Publishing: 247] [Article Influence: 11.8] [Reference Citation Analysis]
109 Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 2011;10:2497-503. [PMID: 21775818 DOI: 10.4161/cc.10.15.16776] [Cited by in Crossref: 156] [Cited by in F6Publishing: 149] [Article Influence: 14.2] [Reference Citation Analysis]
110 Hosoya Y, Gemma A, Seike M, Kurimoto F, Uematsu K, Hibino S, Yoshimura A, Shibuya M, Kudoh S. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Lung Cancer. 1999;25:87-93. [PMID: 10470842 DOI: 10.1016/s0169-5002(99)00052-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
111 de Snoo FA, Hottenga JJ, Gillanders EM, Sandkuijl LA, Jones MP, Bergman W, van der Drift C, van Leeuwen I, van Mourik L, Huurne JA, Frants RR, Willemze R, Breuning MH, Trent JM, Gruis NA. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families. Eur J Hum Genet 2008;16:1135-41. [PMID: 18398432 DOI: 10.1038/ejhg.2008.72] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
112 Erlandsson R. Molecular Genetics of Renal Cell Carcinoma. Cancer Genetics and Cytogenetics 1998;104:1-18. [DOI: 10.1016/s0165-4608(97)00384-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
113 Newcomb EW. P53 Gene Mutations in Lymphoid Diseases and Their Possible Relevance to Drug Resistance. Leukemia & Lymphoma 2009;17:211-21. [DOI: 10.3109/10428199509056825] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
114 Tang KS, Guralnick BJ, Wang WK, Fersht AR, Itzhaki LS. Stability and folding of the tumour suppressor protein p16. J Mol Biol 1999;285:1869-86. [PMID: 9917418 DOI: 10.1006/jmbi.1998.2420] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
115 Zhao GH, Li TC, Shi LH, Xia YB, Lu LM, Huang WB, Sun HL, Zhang YS. Relationship between inactivation of p16 gene and gastric carcinoma. World J Gastroenterol 2003; 9(5): 905-909 [PMID: 12717828 DOI: 10.3748/wjg.v9.i5.905] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
116 Satra M, Vamvakopoulou DN, Sioutopoulou DO, Kollia P, Kiritsaka A, Sotiriou S, Antonakopoulos G, Alexandris E, Costantoulakis P, Vamvakopoulos NC. Sequence-based genotyping HPV L1 DNA and RNA transcripts in clinical specimens. Pathology - Research and Practice 2009;205:863-9. [DOI: 10.1016/j.prp.2009.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
117 Wang P, Greiner TC, Lushnikova T, Eischen CM. Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. Oncogene 2006;25:3708-18. [DOI: 10.1038/sj.onc.1209411] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
118 Hall PA, Lane DP. Genetics of growth arrest and cell death: key determinants of tissue homeostasis. Eur J Cancer 1994;30A:2001-12. [PMID: 7734214 DOI: 10.1016/0959-8049(94)00394-k] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
119 Ramel S. Barrett's esophagus: model of neoplastic progression. World J Surg. 2003;27:1009-1013. [PMID: 12917763 DOI: 10.1007/s00268-003-7053-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
120 Kittler H, Tschandl P. Dysplastic nevus: why this term should be abandoned in dermatoscopy. Dermatol Clin 2013;31:579-88, viii. [PMID: 24075546 DOI: 10.1016/j.det.2013.06.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
121 Yoo WJ, Cho SH, Lee YS, Park GS, Kim MS, Kim BK, Park WS, Lee JY, Kang CS. Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx. J Korean Med Sci. 2004;19:345-351. [PMID: 15201498 DOI: 10.3346/jkms.2004.19.3.345] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
122 Carney DN. Lung cancer biology. Seminars in Radiation Oncology 1995;5:4-10. [DOI: 10.1016/s1053-4296(05)80003-7] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
123 Kohno T, Kawanishi M, Matsuda S, Ichikawa H, Takada M, Ohki M, Yamamoto T, Yokota J. Homozygous deletion and frequent allelic loss of the 21q11.1-q21.1 region including theANA gene in human lung carcinoma. Genes Chromosom Cancer 1998;21:236-43. [DOI: 10.1002/(sici)1098-2264(199803)21:3<236::aid-gcc8>3.0.co;2-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
124 Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer. 1999;80:79-86. [PMID: 10389982 DOI: 10.1038/sj.bjc.6690505] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
125 Houlston RS, Peto J. Genetics and the common cancers. In: Eeles RA, Ponder BAJ, Easton DF, Horwich A, editors. Genetic Predisposition to Cancer. Boston: Springer US; 1996. pp. 208-26. [DOI: 10.1007/978-1-4899-4501-3_13] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
126 Tigan AS, Bellutti F, Kollmann K, Tebb G, Sexl V. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation. Oncogene 2016;35:3083-91. [PMID: 26500059 DOI: 10.1038/onc.2015.407] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 10.9] [Reference Citation Analysis]
127 Gonzalgo ML, Jones PA. Mutagenic and epigenetic effects of DNA methylation. Mutation Research/Reviews in Mutation Research 1997;386:107-18. [DOI: 10.1016/s1383-5742(96)00047-6] [Cited by in Crossref: 152] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
128 Gao HJ, Yu LZ, Bai JF, Peng YS, Sun G, Zhao HL, Miu K, Lü XZ, Zhang XY, Zhao ZQ. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological types and staging. World J Gastroenterol 2000; 6(6): 848-854 [PMID: 11819707 DOI: 10.3748/wjg.v6.i6.848] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.6] [Reference Citation Analysis]
129 Pollock RE. Molecular determinants of soft tissue sarcoma proliferation. Semin Surg Oncol 1994;10:315-22. [PMID: 7997725 DOI: 10.1002/ssu.2980100503] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
130 Panagopoulos I, Heim S. Interstitial Deletions Generating Fusion Genes. Cancer Genomics Proteomics 2021;18:167-96. [PMID: 33893073 DOI: 10.21873/cgp.20251] [Reference Citation Analysis]
131 Schmalbach CE, Johnson TM, Bradford CR. The management of head and neck melanoma. Curr Probl Surg 2006;43:781-835. [PMID: 17112819 DOI: 10.1067/j.cpsurg.2006.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
132 Palanca-Wessels MC, Barrett MT, Galipeau PC, Rohrer KL, Reid BJ, Rabinovitch PS. Genetic analysis of long-term Barrett’s esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology. 1998;114:295-304. [PMID: 9453489 DOI: 10.1016/s0016-5085(98)70480-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
133 Hirai H. Molecular pathogenesis of MDS. Int J Hematol 2002;76:213-21. [DOI: 10.1007/bf03165120] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
134 Hoefling NL, McHugh JB, Light E, Kumar B, Walline H, Prince M, Bradford C, Carey TE, Mukherji SK. Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34:1062-6, S1-2. [PMID: 23370473 DOI: 10.3174/ajnr.A3349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
135 Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol 2002;22:1360-8. [PMID: 11839803 DOI: 10.1128/MCB.22.5.1360-1368.2002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
136 Kawamata N, Seriu T, Koeffler HP, Bartram CR. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer 1996;77:570-5. [DOI: 10.1002/(sici)1097-0142(19960201)77:3<570::aid-cncr21>3.0.co;2-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
137 Martin A, Baran-Marzak F, El Mansouri S, Legendre C, Leblond V, Charlotte F, Davi F, Canioni D, Raphaël M. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders. Am J Pathol 2000;156:1573-9. [PMID: 10793069 DOI: 10.1016/S0002-9440(10)65029-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
138 Sawada M, Inase N, Imai M, Ohtani Y, Miyake S, Akamatsu H, Yoshizawa Y. Chromosome 9p deletion in squamous metaplasia in cystic lesion of the lung. Respirology 2003;8:239-42. [PMID: 12753542 DOI: 10.1046/j.1440-1843.2003.00450.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
139 Gerstenblith MR, Goldstein AM, Tucker MA. Hereditary genodermatoses with cancer predisposition. Hematol Oncol Clin North Am 2010;24:885-906. [PMID: 20816579 DOI: 10.1016/j.hoc.2010.06.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
140 Ma HB, Hu HT, Di ZL, Wang ZR, Shi JS, Wang XJ, Li Y. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol 2005; 11(5): 744-747 [PMID: 15655836 DOI: 10.3748/wjg.v11.i5.744] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
141 Rattan SIS. Aging Outside the Body: Usefulness of the Hayflick System. In: Kaul SC, Wadhwa R, editors. Aging of Cells in and Outside the Body. Dordrecht: Springer Netherlands; 2003. pp. 1-8. [DOI: 10.1007/978-94-017-0669-8_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
142 Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci U S A 1996;93:15215-20. [PMID: 8986790 DOI: 10.1073/pnas.93.26.15215] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 3.2] [Reference Citation Analysis]
143 You J, Dong R, Ying M, He Q, Cao J, Yang B. Cellular Senescence and Anti-Cancer Therapy. Curr Drug Targets 2019;20:705-15. [PMID: 30556499 DOI: 10.2174/1389450120666181217100833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Smith RC, Wills KN, Antelman D, Perlman H, Truong LN, Krasinski K, Walsh K. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation 1997;96:1899-905. [PMID: 9323079 DOI: 10.1161/01.cir.96.6.1899] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
145 Brooks G, La Thangue NB. The cell cycle and drug discovery: the promise and the hope. Drug Discovery Today 1999;4:455-64. [DOI: 10.1016/s1359-6446(99)01400-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
146 Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat Med 1999;5:760-7. [PMID: 10395320 DOI: 10.1038/10480] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 5.0] [Reference Citation Analysis]
147 Fog CK, Jensen KT, Lund AH. Chromatin-modifying proteins in cancer. APMIS 2007;115:1060-89. [PMID: 18042144 DOI: 10.1111/j.1600-0463.2007.apm_776.xml.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
148 Sedlacek HH. Mechanisms of action of flavopiridol. Crit Rev Oncol Hematol 2001;38:139-70. [PMID: 11311660 DOI: 10.1016/s1040-8428(00)00124-4] [Cited by in Crossref: 152] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
149 Fischer T, Gazzola S, Riedl R. Approaching Target Selectivity by De Novo Drug Design. Expert Opin Drug Discov 2019;14:791-803. [PMID: 31179763 DOI: 10.1080/17460441.2019.1615435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
150 Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 1999;246:280-289. [PMID: 9925742 DOI: 10.1006/excr.1998.4319] [Cited by in Crossref: 478] [Cited by in F6Publishing: 464] [Article Influence: 20.8] [Reference Citation Analysis]
151 Lee JY, Dong SM, Shin MS, Kim SY, Lee SH, Kang SJ, Lee JD, Kim CS, Kim SH, Yoo NJ. Genetic Alterations ofp16INK4aandp53Genes in Sporadic Dysplastic Nevus. Biochemical and Biophysical Research Communications 1997;237:667-72. [DOI: 10.1006/bbrc.1997.7212] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
152 Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Molecular biology of adenoid cystic carcinoma. Head Neck 2012;34:1665-77. [PMID: 22006498 DOI: 10.1002/hed.21849] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
153 Zhang B, Zhu W, Yang P, Liu T, Jiang M, He ZN, Zhang SX, Chen WQ, Chen W. Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis. PLoS One 2011;6:e28882. [PMID: 22174919 DOI: 10.1371/journal.pone.0028882] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
154 Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 1995;12:255-61. [PMID: 7539279 DOI: 10.1002/gcc.2870120404] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 2.2] [Reference Citation Analysis]
155 Gartel AL, Tyner AL. The growth-regulatory role of p21 (WAF1/CIP1). Prog Mol Subcell Biol. 1998;20:43-71. [PMID: 9928526 DOI: 10.1007/978-3-642-72149-6_4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
156 Reynolds SE, Billett MA, Gordon C, Colleaux L, Kloetzel PM, Tanaka K, Dawson SP, Arnold JE, Mayer NJ, Mayer RJ. Developmental Changes of the 26 S Proteasome in Abdominal Intersegmental Muscles of Manduca sexta during Programmed Cell Death. Journal of Biological Chemistry 1995;270:1850-8. [DOI: 10.1074/jbc.270.4.1850] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 3.9] [Reference Citation Analysis]
157 Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells. Oncogene 2001;20:6840-50. [PMID: 11687963 DOI: 10.1038/sj.onc.1204790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
158 Hansson J. Familial cutaneous melanoma. Adv Exp Med Biol 2010;685:134-45. [PMID: 20687502 DOI: 10.1007/978-1-4419-6448-9_13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
159 Piao Z, Park C, Lee J, Yang CH, Choi KY, Kim H. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma. Cancer Letters 1998;122:201-7. [DOI: 10.1016/s0304-3835(97)00403-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
160 White J, Dalton S. Cell cycle control of embryonic stem cells. Stem Cell Rev 2005;1:131-8. [PMID: 17142847 DOI: 10.1385/SCR:1:2:131] [Cited by in Crossref: 223] [Cited by in F6Publishing: 149] [Article Influence: 14.9] [Reference Citation Analysis]
161 Gaidano G, Dalla-favera R. Molecular Pathogenesis of Aids-Related Lymphomas. Elsevier; 1995. pp. 113-53. [DOI: 10.1016/s0065-230x(08)60712-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
162 Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996;73:649-53. [PMID: 8605102 DOI: 10.1038/bjc.1996.113] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
163 Uchida T. Small hepatocellular carcinoma: its relationship to multistep hepatocarcinogenesis. Pathol Int. 1995;45:175-184. [PMID: 7787987 DOI: 10.1111/j.1440-1827.1995.tb03440.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
164 Rush EB, Abouezzi Z, Borgen PI, Anelli A. Analysis of MTS1/CDK4 in female breast carcinomas. Cancer Letters 1995;89:223-6. [DOI: 10.1016/0304-3835(95)03691-o] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
165 Farid NR, Zou M, Shi Y. Genetics of Follicular Thyroid Cancer. Endocrinology and Metabolism Clinics of North America 1995;24:865-83. [DOI: 10.1016/s0889-8529(18)30024-0] [Cited by in Crossref: 27] [Article Influence: 1.0] [Reference Citation Analysis]
166 Shan Z, Shakoori A, Bodaghi S, Goldsmith P, Jin J, Wiest JS. TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One 2013;8:e66114. [PMID: 23776618 DOI: 10.1371/journal.pone.0066114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
167 Nakayama T, Taback B, Nguyen DH, Chi DD, Morton DL, Fujiwara Y, Hoon DS. Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients. Ann N Y Acad Sci 2000;906:87-98. [PMID: 10818602 DOI: 10.1111/j.1749-6632.2000.tb06596.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
168 Fleshner N, Garland J, Moadel A, Herr H, Ostroff J, Trambert R, O'sullivan M, Russo P. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999;86:2337-45. [DOI: 10.1002/(sici)1097-0142(19991201)86:11<2337::aid-cncr23>3.0.co;2-6] [Cited by in Crossref: 121] [Article Influence: 5.3] [Reference Citation Analysis]
169 Ito N, Sawa H, Nagane M, Noguchi A, Hara M, Saito I. Inhibitory Effects of Sodium Butyrate on Proliferation and Invasiveness of Human Glioma Cells: . Neurosurgery 2001;49:430-7. [DOI: 10.1227/00006123-200108000-00031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
170 Wang Y, Uhara H, Yamazaki Y, Nikaido T, Saida T. Immunohistochemical detection of CDK4 and 9 16 INK4 proteins in cutaneous malignant melanoma. British Journal of Dermatology 1996;134:269-75. [DOI: 10.1111/j.1365-2133.1996.tb07612.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
171 Qureshi MA, Jan N, Dar NA, Hussain M, Andrabi KI. A novel p16 INK4A mutation associated with esophageal squamous cell carcinoma in a high risk population. Biomarkers 2012;17:552-6. [DOI: 10.3109/1354750x.2012.699556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
172 Kawakami Y, Sumimoto H, Fujita T, Matsuzaki Y. Immunological detection of altered signaling molecules involved in melanoma development. Cancer Metastasis Rev 2005;24:357-66. [DOI: 10.1007/s10555-005-1583-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
173 Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141-196. [PMID: 9338076 DOI: 10.1016/s0065-230x(08)60702-2] [Cited by in Crossref: 1168] [Cited by in F6Publishing: 12] [Article Influence: 46.7] [Reference Citation Analysis]
174 Skolnick M, Cannon-albright L, Kamb A. Genetic predisposition to melanoma. European Journal of Cancer 1994;30:1991-5. [DOI: 10.1016/0959-8049(94)00392-i] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
175 Walker GJ, Palmer JM, Walters MK, Hayward NK. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes Cancer 1995;12:134-41. [PMID: 7535086 DOI: 10.1002/gcc.2870120208] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 2.5] [Reference Citation Analysis]
176 Rassekh CH, Rady PL, Arany I, Tyring SK, Knudsen S, Calhoun KH, Seikaly H, Bailey BJ. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope 1998;108:362-7. [PMID: 9504608 DOI: 10.1097/00005537-199803000-00010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
177 Hruban RH, Klimstra DS, Zamboni G, Klöppel G. A semicentennial of pancreatic pathology: the genetic revolution is here, but don't throw the baby out with the bath water! Hum Pathol 2020;95:99-112. [PMID: 31521627 DOI: 10.1016/j.humpath.2019.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
178 He Z, Chen Y, Hou C, He W, Chen P. Cigarette Smoke Extract Changes Expression of Endothelial Nitric Oxide Synthase (eNOS) and p16(INK4a) and is Related to Endothelial Progenitor Cell Dysfunction. Med Sci Monit 2017;23:3224-31. [PMID: 28668968 DOI: 10.12659/msm.902746] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
179 Herzog CR, Noh S, Lantry LE, Guan K, You M. Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis. Mol Carcinog 1999;25:92-8. [DOI: 10.1002/(sici)1098-2744(199906)25:2<92::aid-mc3>3.0.co;2-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
180 Walker GJ, Flores JF, Glendening JM, Lin A(, Markl IDC, Fountain JW. Virtually 100% of melanoma cell lines harbor alterations at the DNA level withinCDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosom Cancer 1998;22:157-63. [DOI: 10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n] [Cited by in Crossref: 88] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
181 Pollock PM, Pearson JV, Hayward NK. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer 1996;15:77-88. [PMID: 8834170 DOI: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
182 Carey WP Jr, Thompson CJ, Synnestvedt M, Guerry D 4th, Halpern A, Schultz D, Elder DE. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994;74:3118-25. [PMID: 7982177 DOI: 10.1002/1097-0142(19941215)74:12<3118::aid-cncr2820741210>3.0.co;2-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
183 Hinshelwood RA, Clark SJ. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J Mol Med (Berl) 2008;86:1315-28. [PMID: 18716754 DOI: 10.1007/s00109-008-0386-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
184 Poolman RA, Gilchrist R, Brooks G. Cell cycle profiles and expressions of p21CIP1 and p27KIP1 during myocyte development. International Journal of Cardiology 1998;67:133-42. [DOI: 10.1016/s0167-5273(98)00320-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
185 Balázs M, Adám Z, Treszl A, Bégány A J, Adány R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry. 2001;46:222-232. [PMID: 11514955 DOI: 10.1002/cyto.1131] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
186 Zhang ZY, Cai JJ, Hong J, Li KK, Ping Z, Wang Y, Ng HK, Yao Y, Mao Y. Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation. Med Oncol 2016;33:99. [PMID: 27449774 DOI: 10.1007/s12032-016-0799-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
187 Abucham J, Vieira TC. Adenomas hipofisários produtores de glicoproteínas: patogênese, diagnóstico e tratamento. Arq Bras Endocrinol Metab 2005;49:657-73. [DOI: 10.1590/s0004-27302005000500007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
188 Fargnoli MC, Chimenti S, Keller G, Soyer HP, Dal Pozzo V, Höfler H, Peris K. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol 1998;111:1202-6. [PMID: 9856841 DOI: 10.1046/j.1523-1747.1998.00412.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
189 Fargnoli MC, Argenziano G, Zalaudek I, Peris K. High- and low-penetrance cutaneous melanoma susceptibility genes. Expert Review of Anticancer Therapy 2014;6:657-70. [DOI: 10.1586/14737140.6.5.657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
190 Kinoshita H, Yamada H, Ogawa O, Kakehi Y, Osaka M, Nakamura E, Mishina M, Habuchi T, Takahashi R, Sugiyama T. Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma. Jpn J Cancer Res 1995;86:795-9. [PMID: 7591954 DOI: 10.1111/j.1349-7006.1995.tb03087.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
191 Sakata K. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 1996;25:302-7. [DOI: 10.1111/j.1600-0714.1996.tb00266.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
192 Massi D, Sardi I, Urso C, Franchi A, Borgognoni L, Salvadori A, Giannini A, Reali UM, Santucci M. Microsatellite analysis in cutaneous malignant melanoma: . Melanoma Research 2002;12:577-84. [DOI: 10.1097/00008390-200212000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
193 Labib K, Moreno S, Nurse P. Interaction of cdc2 and rum1 regulates Start and S-phase in fission yeast. Journal of Cell Science 1995;108:3285-94. [DOI: 10.1242/jcs.108.10.3285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
194 Itahana K, Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 2008;13:542-53. [PMID: 18538737 DOI: 10.1016/j.ccr.2008.04.002] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 7.1] [Reference Citation Analysis]
195 Smedley D, Sidhar S, Birdsall S, Bennett D, Herlyn M, Cooper C, Shipley J. Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosom Cancer 2000;28:121-5. [DOI: 10.1002/(sici)1098-2264(200005)28:1<121::aid-gcc14>3.0.co;2-o] [Cited by in Crossref: 55] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
196 Lin YW, Chen CH, Huang GT, Lee PH, Wang JT, Chen DS, Lu FJ, Sheu JC. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer 1998;34:1789-95. [PMID: 9893670 DOI: 10.1016/s0959-8049(98)00189-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
197 Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene 1999;18:1197-203. [DOI: 10.1038/sj.onc.1202452] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 3.7] [Reference Citation Analysis]
198 Hatta Y, Yamada Y, Tomonaga M, Said JW, Miyosi I, Koeffler HP. Allelotype Analysis of Adult T-Cell Leukemia. Blood 1998;92:2113-7. [DOI: 10.1182/blood.v92.6.2113.418k25_2113_2117] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
199 Gupta S. Hepatic polyploidy and liver growth control. Semin Cancer Biol. 2000;10:161-171. [PMID: 10936066 DOI: 10.1006/scbi.2000.0317] [Cited by in Crossref: 182] [Cited by in F6Publishing: 167] [Article Influence: 8.3] [Reference Citation Analysis]
200 Sasaki S, Kitagawa Y, Sekido Y, Minna JD, Kuwano H, Yokota J, Kohno T. Molecular processes of chromosome 9p21 deletions in human cancers. Oncogene. 2003;22:3792-3798. [PMID: 12802286 DOI: 10.1038/sj.onc.1206589] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
201 Misra RN, Xiao H, Kim KS, Lu S, Han W, Barbosa SA, Hunt JT, Rawlins DB, Shan W, Ahmed SZ, Qian L, Chen B, Zhao R, Bednarz MS, Kellar KA, Mulheron JG, Batorsky R, Roongta U, Kamath A, Marathe P, Ranadive SA, Sack JS, Tokarski JS, Pavletich NP, Lee FYF, Webster KR, Kimball SD. N -(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N -[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent. J Med Chem 2004;47:1719-28. [DOI: 10.1021/jm0305568] [Cited by in Crossref: 186] [Cited by in F6Publishing: 155] [Article Influence: 10.3] [Reference Citation Analysis]
202 Jennings GS, Strauss M. Immortalization of Hepatocytes through Targeted Deregulation of the Cell Cycle. In: Al-rubeai M, editor. Cell Engineering. Dordrecht: Springer Netherlands; 1999. pp. 255-87. [DOI: 10.1007/978-0-585-37971-5_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996;85:27-37. [PMID: 8620534 DOI: 10.1016/s0092-8674(00)81079-x] [Cited by in Crossref: 1087] [Cited by in F6Publishing: 452] [Article Influence: 41.8] [Reference Citation Analysis]
204 Uchida T, Kinoshita T, Hotta T, Murate T. High-Risk Myelodysplastic Syndromes and Hypermethylation of the p15 Ink4B Gene. Leukemia & Lymphoma 2009;32:9-18. [DOI: 10.3109/10428199809059242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
205 Schneider-Stock R, Boltze C, Lasota J, Miettinen M, Peters B, Pross M, Roessner A, Günther T. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol. 2003;21:1688-1697. [PMID: 12721243 DOI: 10.1200/jco.2003.08.101] [Cited by in Crossref: 111] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
206 Huber J, Ramos ES. The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma. Braz J Med Biol Res 2006;39:237-41. [PMID: 16470311 DOI: 10.1590/s0100-879x2006000200010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
207 Pal A, Potjer TP, Thomsen SK, Ng HJ, Barrett A, Scharfmann R, James TJ, Bishop DT, Karpe F, Godsland IF, Vasen HF, Newton-Bishop J, Pijl H, McCarthy MI, Gloyn AL. Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans. Diabetes 2016;65:527-33. [PMID: 26542317 DOI: 10.2337/db15-0602] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
208 Ping Z, Siegal GP, Almeida JS, Schnitt SJ, Shen D. Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology. J Pathol Inform 2014;5:3. [PMID: 24672738 DOI: 10.4103/2153-3539.126147] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
209 Kai M, Arakawa H, Sugimoto Y, Murata Y, Ogawa M, Nakamura Y. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas. Jpn J Cancer Res 1995;86:249-51. [PMID: 7744694 DOI: 10.1111/j.1349-7006.1995.tb03047.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
210 Doria A, Wojcik J, Xu R, Gervino EV, Hauser TH, Johnstone MT, Nolan D, Hu FB, Warram JH. Interaction between poor glycemic control and 9p21 Locus on risk of coronary artery disease in type 2 diabetes. JAMA. 2008;300:2389-2397. [PMID: 19033589 DOI: 10.1001/jama.2008.649] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
211 Gomi A, Sakai R, Ogawa S, Shinoda S, Hirai H, Masuzawa T. Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas. Jpn J Cancer Res 1995;86:342-6. [PMID: 7775255 DOI: 10.1111/j.1349-7006.1995.tb03062.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
212 Fogt F, Vortmeyer AO, Stolte M, Mueller E, Mueller J, Noffsinger A, Poremba C, Zhuang Z. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. Hum Pathol 1998;29:961-4. [PMID: 9744312 DOI: 10.1016/s0046-8177(98)90201-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
213 Kiaris H, Spandidos DA. Quantitation of the allelic imbalance provides evidence on tumour heterogeneity: a hypothesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1996;354:35-9. [DOI: 10.1016/0027-5107(96)00008-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
214 Arentson E, Faloon P, Seo J, Moon E, Studts JM, Fremont DH, Choi K. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene 2002;21:1150-8. [PMID: 11850834 DOI: 10.1038/sj.onc.1205175] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 5.0] [Reference Citation Analysis]
215 Gao X, Honn KV. Recessive oncogenes: current status. Pathol Oncol Res 1995;1:7-22. [PMID: 11173562 DOI: 10.1007/BF02893578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, A Al-Hussein K, Aboussekhra A. The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 2004;23:201-12. [PMID: 14712225 DOI: 10.1038/sj.onc.1206927] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
217 Little M, Wainwright B. Methylation and p16: Suppressing the suppressor. Nat Med 1995;1:633-4. [DOI: 10.1038/nm0795-633] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
218 Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene. 2002;21:3475-3495. [PMID: 12032783 DOI: 10.1038/sj.onc.1205322] [Cited by in Crossref: 157] [Cited by in F6Publishing: 134] [Article Influence: 7.9] [Reference Citation Analysis]
219 Larsen JE, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med. 2011;32:703-740. [PMID: 22054881 DOI: 10.1016/j.ccm.2011.08.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 112] [Article Influence: 11.5] [Reference Citation Analysis]
220 Sano H, Shimada A, Tabuchi K, Taki T, Murata C, Park MJ, Ohki K, Sotomatsu M, Adachi S, Tawa A, Kobayashi R, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group. Int J Hematol. 2013;98:437-445. [PMID: 23979985 DOI: 10.1007/s12185-013-1409-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
221 Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, Louis G, Moses M, Arbiser JL. Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling. Journal of Biological Chemistry 2003;278:9790-5. [DOI: 10.1074/jbc.m212929200] [Cited by in Crossref: 90] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
222 Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 2003;22:4444-8. [PMID: 12853981 DOI: 10.1038/sj.onc.1206564] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
223 Müllner EW, Dolznig H, Beug H. Cell cycle regulation and erythroid differentiation. Curr Top Microbiol Immunol 1996;212:175-94. [PMID: 8934819 DOI: 10.1007/978-3-642-80057-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
224 Park SH, Maeda T, Mohapatra G, Waldman FM, Davis RL, Feuerstein BG. Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme. Cancer Genetics and Cytogenetics 1995;83:127-35. [DOI: 10.1016/0165-4608(95)00040-v] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
225 Volm M, Koomägi R, Stammler G, Rittgen W, Zintl F, Sauerbrey A. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRb, p16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 1997;74:508-12. [DOI: 10.1002/(sici)1097-0215(19971021)74:5<508::aid-ijc5>3.0.co;2-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
226 Abdullah JM, Zainuddin N, Sulong S, Jaafar H, Isa MN. Molecular genetic analysis of phosphatase and tensin homolog and p16 tumor suppressor genes in patients with malignant glioma. FOC 2003;14:1-7. [DOI: 10.3171/foc.2003.14.4.6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
227 Mou Z, Wang Y, Li Y. Brazilein induces apoptosis and G1/G0 phase cell cycle arrest by up-regulation of miR-133a in human vestibular schwannoma cells. Experimental and Molecular Pathology 2019;107:95-101. [DOI: 10.1016/j.yexmp.2018.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
228 Cho YS, Angove H, Brain C, Chen CH, Cheng H, Cheng R, Chopra R, Chung K, Congreve M, Dagostin C, Davis DJ, Feltell R, Giraldes J, Hiscock SD, Kim S, Kovats S, Lagu B, Lewry K, Loo A, Lu Y, Luzzio M, Maniara W, McMenamin R, Mortenson PN, Benning R, O'Reilly M, Rees DC, Shen J, Smith T, Wang Y, Williams G, Woolford AJ, Wrona W, Xu M, Yang F, Howard S. Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors. ACS Med Chem Lett 2012;3:445-9. [PMID: 24900493 DOI: 10.1021/ml200241a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
229 Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 1999;18:1185-96. [PMID: 10022124 DOI: 10.1038/sj.onc.1202385] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
230 Wang D, Zhou C, Zhang X. The birhythmicity increases the diversity of p53 oscillation induced by DNA damage. Chinese Phys B 2017;26:128709. [DOI: 10.1088/1674-1056/26/12/128709] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
231 Gursky S, Olopade OI, Rowley JD. Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. Cancer Genet Cytogenet 2001;129:93-101. [PMID: 11566337 DOI: 10.1016/s0165-4608(01)00444-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
232 Simon M, Simon C, Köster G, Hans VH, Schramm J. Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression. J Neurooncol 2002;60:1-12. [PMID: 12416540 DOI: 10.1023/a:1020226130478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
233 Ghazizadeh M, Jin E, Shimizu H, Fujiwara M, Arai S, Ohaki Y, Takemura T, Kawanami O. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Respiration 2005;72:68-73. [PMID: 15753637 DOI: 10.1159/000083403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
234 Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330. [PMID: 7736585 DOI: 10.1016/0092-8674(95)90385-2] [Cited by in Crossref: 3243] [Cited by in F6Publishing: 3174] [Article Influence: 120.1] [Reference Citation Analysis]
235 Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, Seto M. The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma. Jpn J Cancer Res 1995;86:890-8. [PMID: 7591969 DOI: 10.1111/j.1349-7006.1995.tb03102.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
236 McGarvey TW, Malkowicz SB. The role of the cell cycle in genitourinary carcinoma. World J Urol 1996;14:310-7. [PMID: 8912471 DOI: 10.1007/BF00184603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
237 Liu YT, Carson DA. A novel approach for determining cancer genomic breakpoints in the presence of normal DNA. PLoS One 2007;2:e380. [PMID: 17440616 DOI: 10.1371/journal.pone.0000380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
238 Li YS, Ramsay DA, Fan Y, Armstrong RF, Del Maestro RF. Cytogenetic evidence that a tumor suppressor gene in the long arm of chromosome 1 contributes to glioma growth. Cancer Genetics and Cytogenetics 1995;84:46-50. [DOI: 10.1016/0165-4608(95)00065-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
239 Piepkorn M. Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors. Journal of the American Academy of Dermatology 2000;42:705-26. [DOI: 10.1067/mjd.2000.104687] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
240 Pipkin J, Hinson W, James S, Lyn-cook L, Duffy P, Feuers R, Shaddock J, Aly K, Hart R, Casciano D. p53 synthesis and phosphorylation in the aging diet-restricted rat following retinoic acid administration. Mechanisms of Ageing and Development 1997;97:15-34. [DOI: 10.1016/s0047-6374(97)01896-4] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
241 Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000;14:3051-64. [PMID: 11114893 DOI: 10.1101/gad.847700] [Cited by in Crossref: 283] [Cited by in F6Publishing: 300] [Article Influence: 13.5] [Reference Citation Analysis]
242 Bogdan I, Smolle J, Kerl H, Burg G, Böni R. Melanoma ex naevo: a study of the associated naevus. Melanoma Research 2003;13:213-7. [DOI: 10.1097/00008390-200304000-00018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
243 Aftab A, Shahzad S, Hussain HMJ, Khan R, Irum S, Tabassum S. CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis. Breast Cancer 2019;26:11-28. [DOI: 10.1007/s12282-018-0894-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
244 Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F, Tahara E. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch. 1996;429:13-19. [PMID: 8865848 DOI: 10.1007/BF00196815] [Cited by in Crossref: 38] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
245 Okajima E, Fukuda T, Okita S, Tsutsumi M, Hirao Y, Okajima E, Konishi Y. Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers. Cancer Letters 1996;103:227-31. [DOI: 10.1016/0304-3835(96)04225-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
246 Giroux MA, Audrezet MP, Metges JP, Lozac'h P, Volant A, Nousbaum JB, Labat JP, Gouérou H, Ferec C, Robaszkiewicz M. Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus. Eur J Gastroenterol Hepatol. 2002;14:15-18. [PMID: 11782570 DOI: 10.1097/00042737-200201000-00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
247 Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarrè M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 2003;77:2195-206. [PMID: 12525654 DOI: 10.1128/jvi.77.3.2195-2206.2003] [Cited by in Crossref: 144] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
248 Arnold JM, Woollatt E, Chenevix-trench G. Chromosome 8 genetic analysis and phenotypic characterization of 21 ovarian cancer cell lines. Cancer Genetics and Cytogenetics 2002;139:109-14. [DOI: 10.1016/s0165-4608(02)00617-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
249 Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A'rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E, Dadkhah E. p16 promoter hypermethylation: A useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008; 14(13): 2055-2060 [PMID: 18395906 DOI: 10.3748/wjg.14.2055] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
250 Thomas A, Cannon-Albright L, Bansal A, Skolnick MH. Familial associations between cancer sites. Comput Biomed Res 1999;32:517-29. [PMID: 10587469 DOI: 10.1006/cbmr.1999.1525] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
251 Kiaris H, Spanakis N, Ergazaki M, Sourvinos G, Spandidos DA. Loss of heterozygosity at 9p and 17q in human laryngeal tumors. Cancer Lett 1995;97:129-34. [PMID: 7585472 DOI: 10.1016/0304-3835(95)03963-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
252 Yamada Y, Kamihira S. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma. Leukemia & Lymphoma 2009;46:1553-9. [DOI: 10.1080/10428190500244217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
253 Gao X, Honn KV. Chapter 5 Molecular biology of prostate cancer. The Oncobiology of the Prostate. Elsevier; 1999. pp. 85-122. [DOI: 10.1016/s1569-254x(99)80006-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
254 Haanen C, Vermes I. Apoptosis and inflammation. Mediators Inflamm 1995;4:5-15. [PMID: 18475609 DOI: 10.1155/S0962935195000020] [Cited by in Crossref: 75] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
255 Fujii GH, Morimoto AM, Berson AE, Bolen JB. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene 1999;18:1765-9. [PMID: 10208437 DOI: 10.1038/sj.onc.1202492] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.5] [Reference Citation Analysis]
256 Teh BT, Grimmond S, Shepherd J, Larsson C, Hayward N. MULTIPLE ENDOCRINE NEOPLASIA TYPE I: CLINICAL SYNDROME TO MOLECULAR GENETICS. ANZ J Surg 1995;65:708-13. [DOI: 10.1111/j.1445-2197.1995.tb00541.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
257 Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T, Inazawa J. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005;96:100-10. [PMID: 15723654 DOI: 10.1111/j.1349-7006.2005.00016.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 3.9] [Reference Citation Analysis]
258 Takata M, Hatta N, Takehara K. Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers. Br J Cancer 1997;76:904-8. [PMID: 9328150 DOI: 10.1038/bjc.1997.482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
259 Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 1997;94:14719-24. [PMID: 9405679 DOI: 10.1073/pnas.94.26.14719] [Cited by in Crossref: 285] [Cited by in F6Publishing: 249] [Article Influence: 11.9] [Reference Citation Analysis]
260 Dong Y, Walsh MD, Mcguckin MA, Gabrielli BB, Cummings MC, Wright RG, Hurst T, Khoo SK, Parsons PG. Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. Int J Cancer 1997;74:57-63. [DOI: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f] [Cited by in Crossref: 54] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
261 Zhang WW. Antisense oncogene and tumor suppressor gene therapy of cancer. J Mol Med (Berl) 1996;74:191-204. [PMID: 8740650 DOI: 10.1007/BF00204749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
262 Kitano S, Nakayama T, Yamashita M. Biomarkers for Immune Checkpoint Inhibitors in Melanoma. Front Oncol 2018;8:270. [PMID: 30073150 DOI: 10.3389/fonc.2018.00270] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
263 Sherburn TE, Gale JM, Ley RD. Cloning and Characterization of the CDKN2A and p19ARF Genes from Monodelphis domestica. DNA and Cell Biology 1998;17:975-81. [DOI: 10.1089/dna.1998.17.975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
264 Helsing P, Nymoen DA, Rootwelt H, Vårdal M, Akslen LA, Molven A, Andresen PA. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. Genes Chromosom Cancer 2012;51:654-61. [DOI: 10.1002/gcc.21952] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
265 Bird R. The Cyclin/Cyclin-Dependent Kinase (cdk) Complex. Nuclear Structure and Gene Expression. Elsevier; 1997. pp. 145-74. [DOI: 10.1016/b978-012100160-5/50006-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
266 Schuyer M, van Staveren IL, Klijn JG, vd Burg ME, Stoter G, Henzen-Logmans SC, Foekens JA, Berns EM. Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours. Br J Cancer 1996;74:1069-73. [PMID: 8855976 DOI: 10.1038/bjc.1996.491] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
267 Fujimoto A, Morita R, Hatta N, Takehara K, Takata M. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma. Oncogene 1999;18:2527-32. [DOI: 10.1038/sj.onc.1202803] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
268 Herzog CR, You M. Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene. Mammalian Genome 1997;8:65-6. [DOI: 10.1007/s003359900352] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
269 Fujita M, Enomoto T, Haba T, Nakashima R, Sasaki M, Yoshino K, Wada H, Buzard GS, Matsuzaki N, Wakasa K, Murata Y. Alteration of p16 and p15 genes in common epithelial ovarian tumors. Int J Cancer 1997;74:148-55. [PMID: 9133447 DOI: 10.1002/(sici)1097-0215(19970422)74:2<148::aid-ijc2>3.0.co;2-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
270 Goldberg EK, Glendening JM, Karanjawala Z, Sridhar A, Walker GJ, Hayward NK, Rice AJ, Kurera D, Tebha Y, Fountain JW. Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 2000;67:417-31. [PMID: 10877980 DOI: 10.1086/302999] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
271 Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995;269:1281-4. [PMID: 7652577 DOI: 10.1126/science.7652577] [Cited by in Crossref: 769] [Cited by in F6Publishing: 655] [Article Influence: 28.5] [Reference Citation Analysis]
272 Bramhall SR. The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1998;23:83-100. [PMID: 9629506 DOI: 10.1385/IJGC:23:2:83] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
273 Tigli H, Buyru N, Dalay N. Molecular analysis of the p27/kip1 gene in breast cancer. Mol Diagn. 2005;9:17-21. [PMID: 16035731 DOI: 10.2165/00066982-200509010-00003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
274 Ikuerowo SO, Kuczyk MA, von Wasielewski R, Shittu OB, Jonas U, Machtens S, Serth J. p16INK4a Expression and Clinicopathologic Parameters in Renal Cell Carcinoma. European Urology 2007;51:732-8. [DOI: 10.1016/j.eururo.2006.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
275 Howe JR, Conlon KC. The molecular genetics of pancreatic cancer. Surg Oncol. 1997;6:1-18. [PMID: 9364657 DOI: 10.1016/S0960-7404(97)00001-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
276 Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T. Hypermethylation of the p15INK4B Gene in Myelodysplastic Syndromes. Blood 1997;90:1403-9. [DOI: 10.1182/blood.v90.4.1403] [Cited by in Crossref: 200] [Article Influence: 8.0] [Reference Citation Analysis]
277 Furukawa Y, Terui Y, Sakoe K, Ohta M, Kitagawa S, Miura Y, Saito M. Over-expression and amplification of the CDC2 gene in leukaemia cells. Br J Haematol 1995;90:94-9. [DOI: 10.1111/j.1365-2141.1995.tb03385.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
278 Sotillo R, García JF, Ortega S, Martin J, Dubus P, Barbacid M, Malumbres M. Invasive melanoma in Cdk4-targeted mice. Proc Natl Acad Sci U S A 2001;98:13312-7. [PMID: 11606789 DOI: 10.1073/pnas.241338598] [Cited by in Crossref: 121] [Cited by in F6Publishing: 99] [Article Influence: 5.8] [Reference Citation Analysis]
279 Cave-Riant F, Cuillerier B, Beau-Faller M, Martinet N, Alla F, Bronner C, Schneider A, Oudet P, Gaub MP. Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis. Am J Respir Cell Mol Biol 2002;27:495-502. [PMID: 12356584 DOI: 10.1165/rcmb.4800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
280 Murao K, Yoshioka R, Kubo Y. Human papillomavirus infection in Bowen disease: Negative p53 expression, not p16 INK4a overexpression, is correlated with human papillomavirus-associated Bowen disease. J Dermatol 2014;41:878-84. [DOI: 10.1111/1346-8138.12613] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
281 Ito Y, Kobayashi T, Takeda T, Komoike Y, Wakasugi E, Tamaki Y, Umeshita K, Monden T, Monden M. Immunohistochemical study of cell cycle modulators in G1-S transition in clinical breast cancer tissue. Breast Cancer 1996;3:93-104. [DOI: 10.1007/bf02966969] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
282 Hatta Y, Yamada Y, Tomonaga M, Said JW, Miyosi I, Koeffler HP. Allelotype Analysis of Adult T-Cell Leukemia. Blood 1998;92:2113-7. [DOI: 10.1182/blood.v92.6.2113] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]
283 Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-malek ZA. Cutaneous Photobiology. The Melanocyte vs. the Sun: Who Will Win the Final Round? Pigment Cell Research 2003;16:434-47. [DOI: 10.1034/j.1600-0749.2003.00088.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 6.3] [Reference Citation Analysis]
284 Hall IJ, Gioeli D, Weissman BE, Tlsty TD. Identification of additional complementation groups that regulate genomic instability. Genes Chromosom Cancer 1997;20:103-12. [DOI: 10.1002/(sici)1098-2264(199710)20:2<103::aid-gcc1>3.0.co;2-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
285 Schaefer IM, Enders C, Polten A, Haller F, Frölich AM, Cameron S, Schüler P, Schweiger P, Gunawan B, Beham A. Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol. 2011;135:579-586. [PMID: 21411780 DOI: 10.1309/ajcpz1o7uuuispnr] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
286 Fernández PL, Jares P, Rey MJ, Campo E, Cardesa A. Cell cycle regulators and their abnormalities in breast cancer. Mol Pathol. 1998;51:305-309. [PMID: 10193510 DOI: 10.1136/mp.51.6.305] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
287 Pan J, Xue Y, Wu Y, Wang Y, Shen J. Dicentric (7;9)(p11;p11) is a rare but recurrent abnormality in acute lymphoblastic leukemia: a study of 7 cases. Cancer Genet Cytogenet 2006;169:159-63. [PMID: 16938575 DOI: 10.1016/j.cancergencyto.2006.03.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
288 Lutful Kabir FM, Alvarez CE, Bird RC. Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression. Vet Sci 2015;3:E1. [PMID: 29056711 DOI: 10.3390/vetsci3010001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
289 Eissa S, Ali-Labib R, Khalifa A. Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC). Clin Chim Acta. 2000;300:159-169. [PMID: 10958872 DOI: 10.1016/s0009-8981(00)00317-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
290 Piccinin S, Doglioni C, Maestro R, Vukosavijevic T, Gasparotto D, D'orazi C, Boiocchi M. p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer 1997;74:26-30. [DOI: 10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
291 Swoboda A, Rasin-streden D, Schanab O, Okamoto I, Pehamberger H, Petzelbauer P, Mikula M. Identification of genetic disparity between primary and metastatic melanoma in human patients. Genes Chromosom Cancer 2011;50:680-8. [DOI: 10.1002/gcc.20890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
292 Ivanchuk SM, Mondal S, Dirks PB, Rutka JT. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. J Neurooncol 2001;51:219-29. [PMID: 11407594 DOI: 10.1023/a:1010632309113] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
293 Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 2008;22:1337-44. [PMID: 18483220 DOI: 10.1101/gad.1662908] [Cited by in Crossref: 246] [Cited by in F6Publishing: 240] [Article Influence: 17.6] [Reference Citation Analysis]
294 Goldstein AM, Tucker MA. Genetic Epidemiology of Familial Melanoma. Dermatologic Clinics 1995;13:605-12. [DOI: 10.1016/s0733-8635(18)30066-4] [Cited by in Crossref: 53] [Article Influence: 2.0] [Reference Citation Analysis]
295 Gotoh A, Kao C, Ko S, Hamada K, Liu T, Chung LWK. Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers: . The Journal of Urology. [DOI: 10.1097/00005392-199708000-00106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
296 Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001;81:217-29. [PMID: 11232644 DOI: 10.1038/labinvest.3780230] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 5.4] [Reference Citation Analysis]
297 Engler TA, Furness K, Malhotra S, Sanchez-martinez C, Shih C, Xie W, Zhu G, Zhou X, Conner S, Faul MM, Sullivan KA, Kolis SP, Brooks HB, Patel B, Schultz RM, Dehahn TB, Kirmani K, Spencer CD, Watkins SA, Considine EL, Dempsey JA, Ogg CA, Stamm NB, Anderson BD, Campbell RM, Vasudevan V, Lytle ML. Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles. Bioorganic & Medicinal Chemistry Letters 2003;13:2261-7. [DOI: 10.1016/s0960-894x(03)00461-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
298 Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity. Journal of Biological Chemistry 2005;280:5812-9. [DOI: 10.1074/jbc.m411429200] [Cited by in Crossref: 111] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
299 Sanchez-martinez C, Shih C, Faul MM, Zhu G, Paal M, Somoza C, Li T, Kumrich CA, Winneroski LL, Xun Z, Brooks HB, Patel BK, Schultz RM, Dehahn TB, Spencer CD, Watkins SA, Considine E, Dempsey JA, Ogg CA, Campbell RM, Anderson BA, Wagner J. Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors. Bioorganic & Medicinal Chemistry Letters 2003;13:3835-9. [DOI: 10.1016/s0960-894x(03)00791-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
300 Koffa M, Spandidos DA. Oncogenes and Onco-suppressor Genes in Female Genital Cancer. Ann NY Acad Sci 1997;816:347-55. [DOI: 10.1111/j.1749-6632.1997.tb52160.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
301 Palmieri G, Cossu A, Ascierto PA, Botti G, Strazzullo M, Lissia A, Colombino M, Casula M, Floris C, Tanda F, Pirastu M, Castello G; Melanoma Cooperative Group. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group. Br J Cancer 2000;83:1707-14. [PMID: 11104570 DOI: 10.1054/bjoc.2000.1513] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
302 Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M, Luo Y, Zhao Y, Liu Y, Huang X, Xia Y, Hu J, Parker JS, Marron D, Cui Q, Peng L, Chu J, Li H, Du Z, Han Y, Tan W, Liu Z, Zhan Q, Li Y, Mao W, Wu C, Lin D. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun 2017;8:15290. [PMID: 28548104 DOI: 10.1038/ncomms15290] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 15.4] [Reference Citation Analysis]
303 Gilmore AP, Ohanian V, Spurr NK, Critchley DR. Localisation of the human gene encoding the cytoskeletal protein talin to chromosome 9p. Hum Genet 1995;96:221-4. [PMID: 7635475 DOI: 10.1007/BF00207384] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
304 Packenham JP, Taylor JA, Anna CH, White CM, Devereux TR. Homozygous deletions but no sequence mutations in coding regions ofp15 orp16 in human primary bladder tumors. Mol Carcinog 1995;14:147-51. [DOI: 10.1002/mc.2940140303] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
305 Pines J. p21 inhibits cyclin shock. Nature 1994;369:520-1. [DOI: 10.1038/369520a0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 1.4] [Reference Citation Analysis]
306 Rizos E, Sourvinos G, Spandidos D. Loss of heterozygosity at 8p, 9p and 17q in laryngeal cytological specimens. Oral Oncology 1998;34:519-23. [DOI: 10.1016/s1368-8375(98)00056-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
307 Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996;93:13742-7. [PMID: 8943005 DOI: 10.1073/pnas.93.24.13742] [Cited by in Crossref: 626] [Cited by in F6Publishing: 584] [Article Influence: 25.0] [Reference Citation Analysis]
308 Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Investigation of germline PTEN, p53, p16INK4A/p14ARF, and CDK4 alterations in familial glioma. Am J Med Genet 2000;92:136-41. [DOI: 10.1002/(sici)1096-8628(20000515)92:2<136::aid-ajmg11>3.0.co;2-s] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
309 Versteege I, Medjkane S, Rouillard D, Delattre O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene 2002;21:6403-12. [PMID: 12226744 DOI: 10.1038/sj.onc.1205841] [Cited by in Crossref: 130] [Cited by in F6Publishing: 110] [Article Influence: 6.5] [Reference Citation Analysis]
310 Goodman GE. Prevention of lung cancer. Critical Reviews in Oncology/Hematology 2000;33:187-97. [DOI: 10.1016/s1040-8428(99)00074-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
311 Majore S, Catricalà C, Binni F, Simone PD, Eibenschutz L, Grammatico P. CDKN2A: The IVS2-105A/G Intronic Mutation Found in an Italian Patient Affected by Eight Primary Melanomas. Journal of Investigative Dermatology 2004;122:450-1. [DOI: 10.1046/j.0022-202x.2004.22222.x] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
312 Shirin H, Hibshoosh H, Kawabata Y, Weinstein IB, Moss SF. p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. Helicobacter. 2003;8:66-71. [PMID: 12603618 DOI: 10.1046/j.1523-5378.2003.00125.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
313 Miladi-abdennadher I, Abdelmaksoud-damak R, Ayadi L, Khabir A, Amouri A, Frikha F, Ellouz S, Frikha M, Sellami-boudawara T, Mokdad-gargouri R. Expression of p16INK4a, Alone or Combined With p53, is Predictive of Better Prognosis in Colorectal Adenocarcinoma in Tunisian Patients. Applied Immunohistochemistry & Molecular Morphology 2011;19:562-8. [DOI: 10.1097/pai.0b013e3182143380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
314 Zhang H, Chen ZH, Savarese TM. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines. Cancer Genet Cytogenet 1996;86:22-8. [PMID: 8616780 DOI: 10.1016/0165-4608(95)00157-3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
315 Paolini M, Biagi GL, Bauer C, Cantelli-Forti G. Enzyme evolution and cancer: hypothesis why natural carcinogens are more potent than synthetic ones. Life Sci 1998;63:2141-6. [PMID: 9851305 DOI: 10.1016/s0024-3205(98)00325-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
316 Mitomi H, Fukui N, Tanaka N, Kanazawa H, Saito T, Matsuoka T, Yao T. Aberrant p16((INK4a)) methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity. J Cancer Res Clin Oncol 2010;136:323-31. [PMID: 19779933 DOI: 10.1007/s00432-009-0688-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
317 Kim YB, Lee KH, Sugita K, Yoshida M, Horinouchi S. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. Oncogene 1999;18:2461-70. [PMID: 10229197 DOI: 10.1038/sj.onc.1202564] [Cited by in Crossref: 162] [Cited by in F6Publishing: 145] [Article Influence: 7.0] [Reference Citation Analysis]
318 Attri J, Srinivasan R, Majumdar S, Radotra BD, Wig J. Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. BMC Gastroenterol. 2005;5:22. [PMID: 15985168 DOI: 10.1186/1471-230x-5-22] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
319 Zhang W, Zhu J, Bai J, Jiang H, Liu F, Liu A, Liu P, Ji G, Guan R, Sun D, Ji W, Yu Y, Jin Y, Meng X, Fu S. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549. J Exp Clin Cancer Res 2010;29:74. [PMID: 20565749 DOI: 10.1186/1756-9966-29-74] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
320 Quesnel B, Preudhomme C, Fenaux P. p16 ink4a Gene and Hematological Malignancies. Leukemia & Lymphoma 2009;22:11-24. [DOI: 10.3109/10428199609051724] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
321 Zhang J, Glatfelter AA, Taetle R, Trent JM. Frequent Alterations of Evolutionarily Conserved Regions of Chromosome 1 in Human Malignant Melanoma. Cancer Genetics and Cytogenetics 1999;111:119-23. [DOI: 10.1016/s0165-4608(98)00196-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
322 Chen Y, Takita J, Mizuguchi M, Tanaka K, Ida K, Koh K, Igarashi T, Hanada R, Tanaka Y, Park MJ, Hayashi Y. Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression. Genes Chromosomes Cancer 2007;46:348-58. [PMID: 17243166 DOI: 10.1002/gcc.20416] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
323 Mao L, Papadimitrakopoulou V, Shin DM, Fan Y, Zhou X, Lee JS, Hong WK, El-naggar AK, Shin HC, Clayman G, Lee JJ, Hittelman WN, Lippman SM. Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy. JNCI Journal of the National Cancer Institute 1998;90:1545-51. [DOI: 10.1093/jnci/90.20.1545] [Cited by in Crossref: 112] [Cited by in F6Publishing: 82] [Article Influence: 4.7] [Reference Citation Analysis]
324 Inohara S, Kitagawa K, Kitano Y. TARGET OF SKIN TUMORIGENESIS: CYCLIN D1-CDK4. Int J Dermatol 1996;35:609-13. [DOI: 10.1111/j.1365-4362.1996.tb03681.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
325 Ikuta M, Kamata K, Fukasawa K, Honma T, Machida T, Hirai H, Suzuki-Takahashi I, Hayama T, Nishimura S. Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein. J Biol Chem 2001;276:27548-54. [PMID: 11335721 DOI: 10.1074/jbc.M102060200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
326 Adamovic T, Hamta A, Roshani L, Lü X, Röhme D, Helou K, Klinga-Levan K, Levan G. Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer. Cancer Genet Cytogenet 2008;184:9-21. [PMID: 18558284 DOI: 10.1016/j.cancergencyto.2008.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
327 Abkevich V, Iliev D, Timms KM, Tran T, Skolnick M, Lanchbury JS, Gutin A. Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization. J Biomed Biotechnol 2010;2010:386870. [PMID: 20706610 DOI: 10.1155/2010/386870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
328 Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000;26:29-52. [PMID: 10660490 DOI: 10.1053/ctrv.1999.0144] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 2.5] [Reference Citation Analysis]
329 Fu Z, Ma Z, Wang Q, Lei D, Wang R, Liu C, Pan X. Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis 2008;25:887-92. [DOI: 10.1007/s10585-008-9207-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
330 Rupesh P, Manoj P, Vijay Kumar S. Biomarkers in carcinoma of the gallbladder. Expert Opinion on Medical Diagnostics 2008;2:511-26. [DOI: 10.1517/17530059.2.5.511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
331 Li SP, Wang HY, Li JQ, Zhang CQ, Feng QS, Huang P, Yu XJ, Huang LX, Liang QW, Zeng YX. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol. 2001;34:840-849. [PMID: 11451167 DOI: 10.1016/s0168-8278(01)00047-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
332 Lutful Kabir FM, Deinnocentes P, Bird RC. Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models: C OMPREHENSIVE E XPRESSION P ROFILES OF miRNA s IN CMTs. J Cell Biochem 2015;116:2956-69. [DOI: 10.1002/jcb.25243] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
333 Nam EJ, Kim JW, Kim SW, Kim YT, Kim JH, Yoon BS, Cho NH, Kim S. The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol 2007;104:207-11. [PMID: 17046054 DOI: 10.1016/j.ygyno.2006.07.043] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
334 Piepkorn M. The expression of p16INK4a, the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation. Journal of the American Academy of Dermatology 2000;42:741-5. [DOI: 10.1067/mjd.2000.103988] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
335 Tan X, Anzick SL, Khan SG, Ueda T, Stone G, Digiovanna JJ, Tamura D, Wattendorf D, Busch D, Brewer CC, Zalewski C, Butman JA, Griffith AJ, Meltzer PS, Kraemer KH. Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency. Hum Mutat 2013;34:1250-9. [PMID: 23661601 DOI: 10.1002/humu.22354] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
336 Recio L. Oncogene and tumor suppressor gene alterations in nasal tumors. Mutat Res 1997;380:27-31. [PMID: 9385387 DOI: 10.1016/s0027-5107(97)00124-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
337 Lydiatt WM, Davidson BJ, Shah J, Schantz SP, Chaganti R. The relationship of loss of heterozygosity to tobacco exposure and early recurrence in head and neck squamous cell carcinoma. The American Journal of Surgery 1994;168:437-40. [DOI: 10.1016/s0002-9610(05)80094-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
338 Jang SJ, Park YW, Park MH, Lee JD, Lee YY, Jung TJ, Kim IS, Choi IY, Ki M, Choi BY. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer. Eur J Surg Oncol. 1999;25:157-163. [PMID: 10218458 DOI: 10.1053/ejso.1998.0619] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
339 Arendt T. Alzheimer’s disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience. 2001;102:723-765. [PMID: 11182240 DOI: 10.1016/s0306-4522(00)00516-9] [Cited by in Crossref: 114] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
340 Itoh N, Kakehi Y, Akao T, Kinoshita H, Okada Y, Yoshida O. Concomitant presence of p16/cyclin-dependent kinase 4 and cyclin D/cyclin-dependent kinase 4 complexes in LNCaP prostatic cancer cell line. Jpn J Cancer Res 1997;88:229-33. [PMID: 9140105 DOI: 10.1111/j.1349-7006.1997.tb00371.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
341 Tse JY, Ng H, Lo K, Chong EY, Lam PY, Ng EK, Poon W, Huang DP. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas. Human Pathology 1998;29:1200-7. [DOI: 10.1016/s0046-8177(98)90246-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
342 Singh AD, Croce CM, Wary KK, Shields JA, Donoso LA, Shields CL, Huebner K, Ohta M. Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16). Ophthalmic Genet 1996;17:39-40. [PMID: 8740697 DOI: 10.3109/13816819609057868] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
343 van der Rhee JI, de Snoo FA, Vasen HFA, Mooi WJ, Putter H, Gruis NA, Kukutsch NA, Bergman W. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. J Am Acad Dermatol 2011;65:289-96. [PMID: 21570154 DOI: 10.1016/j.jaad.2010.06.067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
344 Goto T, Takano M, Hirata J, Kohno T, Ohtsuka S, Fujiwara K, Tsuda H. p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer. Int J Cancer 2009;125:339-44. [DOI: 10.1002/ijc.24315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
345 Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol. 1999;287:821-828. [PMID: 10222191 DOI: 10.1006/jmbi.1999.2640] [Cited by in Crossref: 459] [Cited by in F6Publishing: 443] [Article Influence: 20.0] [Reference Citation Analysis]
346 Malumbres M, Pérez De Castro I, Hernández MI, Jiménez M, Corral T, Pellicer A. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol Cell Biol 2000;20:2915-25. [PMID: 10733595 DOI: 10.1128/MCB.20.8.2915-2925.2000] [Cited by in Crossref: 113] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
347 Sonoda Y, Murakami Y, Tominaga T, Kayama T, Yoshimoto T, Sekiya T. Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 1996;87:363-7. [PMID: 8641967 DOI: 10.1111/j.1349-7006.1996.tb00231.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
348 Grandér D, Sangfelt O, Erickson S. How does interferon exert its cell growth inhibitory effect? European Journal of Haematology 1997;59:129-35. [DOI: 10.1111/j.1600-0609.1997.tb00965.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
349 Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M, Buzard G, Murata Y. Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 1999;80:458-67. [PMID: 10408854 DOI: 10.1038/sj.bjc.6690379] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 2.7] [Reference Citation Analysis]
350 Tada M, de Tribolet N. Immunobiology of malignant gliomas. J Clin Neurosci 1996;3:102-13. [PMID: 18638850 DOI: 10.1016/s0967-5868(96)90001-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
351 Serrano M, Gómez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science. 1995;267:249-252. [PMID: 7809631 DOI: 10.1126/science.7809631] [Cited by in Crossref: 266] [Cited by in F6Publishing: 260] [Article Influence: 9.9] [Reference Citation Analysis]
352 Chang T, Wang J, Chen L, Hsu C, Chang H, Chen J, Cho C. Loss of Expression of the p16 Gene Is Frequent in Malignant Skin Tumors. Biochemical and Biophysical Research Communications 1997;230:85-8. [DOI: 10.1006/bbrc.1996.5891] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
353 Cardinali M, Jakus J, Shah S, Ensley J, Robbins K, Yeudall W. p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncology 1998;34:211-8. [DOI: 10.1016/s1368-8375(97)00083-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
354 Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32. [PMID: 18096889 DOI: 10.1177/154405910808700104] [Cited by in Crossref: 259] [Cited by in F6Publishing: 236] [Article Influence: 18.5] [Reference Citation Analysis]
355 Subramaniam MM, Noguera R, Piqueras M, Navarro S, López-guerrero JA, Llombart-bosch A. p16INK4A ( CDKN2A ) Gene Deletion Is a Frequent Genetic Event in Synovial Sarcomas. Am J Clin Pathol 2006;126:866-74. [DOI: 10.1309/e2aay2xxn431wl81] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
356 Chung CT, Santos Gda C, Hwang DM, Ludkovski O, Pintilie M, Squire JA, Tsao MS. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol 2010;63:630-4. [PMID: 20591913 DOI: 10.1136/jcp.2010.076794] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
357 Silva JM, Dominguez G, Villanueva MJ, Gonzalez R, Garcia JM, Corbacho C, Provencio M, España P, Bonilla F. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer 1999;80:1262-4. [PMID: 10376981 DOI: 10.1038/sj.bjc.6690495] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 3.4] [Reference Citation Analysis]
358 Papenberg BW, Ingles J, Gao S, Feng J, Allen JL, Markwell SM, Interval ET, Montague PA, Wen S, Weed SA. Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma. Cancer Genet 2021;256-257:136-48. [PMID: 34130230 DOI: 10.1016/j.cancergen.2021.05.011] [Reference Citation Analysis]
359 Karim BO, Rhee KJ, Liu G, Zheng D, Huso DL. Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice. BMC Cancer. 2013;13:157. [PMID: 23530816 DOI: 10.1186/1471-2407-13-157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
360 Dutton-Regester K, Hayward NK. Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy. Adv Pharmacol 2012;65:399-435. [PMID: 22959033 DOI: 10.1016/B978-0-12-397927-8.00013-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
361 Rumpel CA, Powell SM, Moskaluk CA. Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas. Am J Pathol 1999;154:1329-34. [PMID: 10329585 DOI: 10.1016/S0002-9440(10)65386-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
362 Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, Herman JG, Belinsky SA. Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol 1997;17:1366-74. [PMID: 9032263 DOI: 10.1128/MCB.17.3.1366] [Cited by in Crossref: 102] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
363 Zhang T, Dutton-Regester K, Brown KM, Hayward NK. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res 2016;29:266-83. [PMID: 26833684 DOI: 10.1111/pcmr.12459] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 15.7] [Reference Citation Analysis]
364 Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Cancer Radiother. 2001;5:109-129. [PMID: 11355576 DOI: 10.1016/s1278-3218(01)00087-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
365 Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal: . Current Opinion in Oncology 2000;12:240-5. [DOI: 10.1097/00001622-200005000-00009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
366 Green CL, Khavari PA. Targets for molecular therapy of skin cancer. Seminars in Cancer Biology 2004;14:63-9. [DOI: 10.1016/j.semcancer.2003.11.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
367 Mora J, Alaminos M, de Torres C, Illei P, Qin J, Cheung NK, Gerald WL. Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. Br J Cancer 2004;91:1112-8. [PMID: 15305192 DOI: 10.1038/sj.bjc.6602094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
368 Jagasia AA, Block JA, Diaz MO, Nobori T, Gitelis S, Inerot SE, Iyer AP. Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Letters 1996;105:77-90. [DOI: 10.1016/0304-3835(96)04273-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
369 Platz A, Ringborg U, Hansson J. Hereditary cutaneous melanoma. Seminars in Cancer Biology 2000;10:319-26. [DOI: 10.1006/scbi.2000.0149] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
370 Li Y, Sanson M, Hoang-xaun K, Delattre J, Poisson M, Thomas G, Hamelin R. Incidence of germ-linep53 mutations in patients with gliomas. Int J Cancer 1995;64:383-7. [DOI: 10.1002/ijc.2910640606] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
371 Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K, Yuasa Y. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer. Int J Cancer 2000;87:654-8. [PMID: 10925358 DOI: 10.1002/1097-0215(20000901)87:5<654::aid-ijc6>3.0.co;2-p] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
372 Siebert R, Willers CP, Opalka B. Role of the Cyclin-Dependent Kinase 4 and 6 Inhibitor Gene Family p15, p16, p18 and p19 in Leukemia and Lymphoma. Leukemia & Lymphoma 2009;23:505-20. [DOI: 10.3109/10428199609054859] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
373 Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D. Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood 2000;95:1869-71. [DOI: 10.1182/blood.v95.5.1869.005k09_1869_1871] [Cited by in Crossref: 42] [Article Influence: 1.9] [Reference Citation Analysis]
374 Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 2003;162:1789-806. [PMID: 12759237 DOI: 10.1016/S0002-9440(10)64314-3] [Cited by in Crossref: 152] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
375 Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994;79:573-582. [PMID: 7954824 DOI: 10.1016/0092-8674(94)90543-6] [Cited by in Crossref: 1436] [Cited by in F6Publishing: 1435] [Article Influence: 51.3] [Reference Citation Analysis]
376 Castellano M, Gabrielli BG, Hussussian CJ, Dracopoli NC, Hayward NK. Restoration of CDKN2A into Melanoma Cells Induces Morphologic Changes and Reduction in Growth Rate but Not Anchorage-Independent Growth Reversal. Journal of Investigative Dermatology 1997;109:61-8. [DOI: 10.1111/1523-1747.ep12276538] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
377 Mansour JC, Chen H. Pancreatic endocrine tumors. J Surg Res. 2004;120:139-161. [PMID: 15172200 DOI: 10.1016/j.jss.2003.12.007] [Cited by in Crossref: 108] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
378 van Rensburg EJ, Ponder BA. Molecular genetics of familial breast-ovarian cancer. J Clin Pathol 1995;48:789-95. [PMID: 7490308 DOI: 10.1136/jcp.48.9.789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
379 Trovato R, Cereseto A, Takemoto S, Gessain A, Watanabe T, Waldmann T, Franchini G. Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines. AIDS Res Hum Retroviruses 2000;16:709-13. [PMID: 10826477 DOI: 10.1089/088922200308701] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
380 Chellappan SP, Giordano A, Fisher PB. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol. 1998;227:57-103. [PMID: 9479826 DOI: 10.1007/978-3-642-71941-7_4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
381 Mangold KA, Takahashi H, Brandigi C, Wada T, Wakui S, Furusato M, Boyd J, Chandler FW, Allsbrook WC. p16 (CDKN2/MTS1) Gene Deletions are Rare in Prostatic Carcinomas in the United States and Japan. Journal of Urology 1997;157:1117-20. [DOI: 10.1016/s0022-5347(01)65152-8] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
382 Kamiryo T, Tada K, Shiraishi S, Shinojima N, Nakamura H, Kochi M, Kuratsu J, Saya H, Ushio Y. Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. Journal of Neurosurgery 2002;96:815-22. [DOI: 10.3171/jns.2002.96.5.0815] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
383 Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G. Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes. Oncotarget 2017;8:37332-41. [PMID: 28445153 DOI: 10.18632/oncotarget.16953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
384 Gotoh A, Kao C, Ko S, Hamada K, Liu T, Chung LW. Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers. Journal of Urology 1997;158:636-41. [DOI: 10.1016/s0022-5347(01)64574-9] [Cited by in Crossref: 44] [Article Influence: 1.8] [Reference Citation Analysis]
385 Giefing M, Arnemann J, Martin-Subero JI, Nieländer I, Bug S, Hartmann S, Arnold N, Tiacci E, Frank M, Hansmann ML, Küppers R, Siebert R. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. Br J Haematol 2008;142:916-24. [PMID: 18671701 DOI: 10.1111/j.1365-2141.2008.07262.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
386 Grard M, Chatelain C, Delaunay T, Pons-Tostivint E, Bennouna J, Fonteneau JF. Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy. Front Oncol 2021;11:695770. [PMID: 34249754 DOI: 10.3389/fonc.2021.695770] [Reference Citation Analysis]
387 Greene MH. The genetics of hereditary melanoma and nevi: 1998 Update. Cancer 1999;86:1644-57. [DOI: 10.1002/(sici)1097-0142(19991015)86:8+<1644::aid-cncr3>3.0.co;2-s] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
388 van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract 2010;2010:360136. [PMID: 20631901 DOI: 10.1155/2010/360136] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
389 Ko JY, Lee TC, Hsiao CF, Lin GL, Yen SH, Chen KY, Hsiung CA, Chen PJ, Hsu MM, Jou YS. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma. Cancer. 2002;94:1987-1996. [PMID: 11932901 DOI: 10.1002/cncr.10406] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
390 Cooke SL, Ng CK, Melnyk N, Garcia MJ, Hardcastle T, Temple J, Langdon S, Huntsman D, Brenton JD. Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene 2010;29:4905-13. [PMID: 20581869 DOI: 10.1038/onc.2010.245] [Cited by in Crossref: 114] [Cited by in F6Publishing: 100] [Article Influence: 9.5] [Reference Citation Analysis]
391 Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Carneiro PC, Ferreira Alves VA, Zerbini MCN, Liberman B, Gomes GC, Kirschner MA. Adrenocortical carcinoma: Clinical and laboratory observations. Cancer 2000;88:711-36. [DOI: 10.1002/(sici)1097-0142(20000215)88:4<711::aid-cncr1>3.0.co;2-w] [Cited by in Crossref: 250] [Article Influence: 11.4] [Reference Citation Analysis]
392 Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, Muto T. Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res. 1997;88:855-860. [PMID: 9369933 DOI: 10.1111/j.1349-7006.1997.tb00461.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
393 Chen CF, Yeh SH, Chen DS, Chen PJ, Jou YS. Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11. Genes Chromosomes Cancer. 2005;44:320-328. [PMID: 16075462 DOI: 10.1002/gcc.20247] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
394 Okamoto A, Jiang W, Kim SJ, Spillare EA, Stoner GD, Weinstein IB, Harris CC. Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci U S A 1994;91:11576-80. [PMID: 7972105 DOI: 10.1073/pnas.91.24.11576] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 1.6] [Reference Citation Analysis]
395 Noë M, Hackeng WM, de Leng WWJ, Vergeer M, Vleggaar FP, Morsink FHM, Wood LD, Hruban RH, Offerhaus GJA, Brosens LAA. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM). Am J Surg Pathol 2019;43:1297-302. [PMID: 31261289 DOI: 10.1097/PAS.0000000000001314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
396 Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM, Schalken JA. Homozygous deletions of p16INK4 occur frequently in bilharziasis-associated bladder cancer. Int J Cancer 1996;68:183-7. [DOI: 10.1002/(sici)1097-0215(19961009)68:2<183::aid-ijc7>3.0.co;2-u] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
397 Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38. [PMID: 21489289 DOI: 10.1186/1476-4598-10-38] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 1045] [Article Influence: 91.1] [Reference Citation Analysis]
398 Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C, Peyrat JP. Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 1995;72:351-3. [PMID: 7640217 DOI: 10.1038/bjc.1995.337] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
399 Serra A, Gottardi E, Della Ragione F, Saglio G, Iolascon A. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. Br J Haematol 1995;91:625-9. [PMID: 8555065 DOI: 10.1111/j.1365-2141.1995.tb05358.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
400 Schang LM, Hwang GH, Dynlacht BD, Speicher DW, Bantly A, Schaffer PA, Shilatifard A, Ge H, Shiekhattar R. Human PC4 Is a Substrate-specific Inhibitor of RNA Polymerase II Phosphorylation. Journal of Biological Chemistry 2000;275:6071-4. [DOI: 10.1074/jbc.275.9.6071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
401 Cox R. Human cancer predisposition and the implications for radiological protection. Int J Radiat Biol 1994;66:643-7. [PMID: 7983460 DOI: 10.1080/09553009414551761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
402 Garbe C, Schaumburg-lever G. Klinik und Histologie des malignen Melanoms. In: Garbe C, Dummer R, Kaufmann R, Tilgen W, editors. Dermatologische Onkologie. Berlin: Springer Berlin Heidelberg; 1997. pp. 247-70. [DOI: 10.1007/978-3-642-60622-9_26] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
403 Driscoll B, Wu L, Buckley S, Hall FL, Anderson KD, Warburton D. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am J Physiol 1997;273:L941-9. [PMID: 9374720 DOI: 10.1152/ajplung.1997.273.5.L941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
404 Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet. 1995;11:210-212. [PMID: 7550353 DOI: 10.1038/ng1095-210] [Cited by in Crossref: 416] [Cited by in F6Publishing: 383] [Article Influence: 15.4] [Reference Citation Analysis]
405 Robertson GP, Huang H, Cavenee WK. Identification and Validation of Tumor Suppressor Genes. Molecular Cell Biology Research Communications 1999;2:1-10. [DOI: 10.1006/mcbr.1999.0141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
406 Park DJ, Wilczynski SP, Pham EY, Miller CW, Koeffler HP. Molecular Analysis of the INK4 Family of Genes in Prostate Carcinomas. Journal of Urology 1997;157:1995-9. [DOI: 10.1016/s0022-5347(01)64917-6] [Cited by in Crossref: 17] [Article Influence: 0.7] [Reference Citation Analysis]
407 Gebhardt MC. Molecular Biology of Sarcomas. Orthopedic Clinics of North America 1996;27:421-9. [DOI: 10.1016/s0030-5898(20)32089-7] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
408 Ivinson AJ. p16 and melanoma. Nature 1994;371:180-180. [DOI: 10.1038/371180a0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
409 Jonsson A, Tuominen R, Grafström E, Hansson J, Egyhazi S. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma. J Invest Dermatol 2010;130:2809-17. [PMID: 20703244 DOI: 10.1038/jid.2010.216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
410 Marks ZRC, Campbell N, deWeerd NA, Lim SS, Gearing LJ, Bourke NM, Hertzog PJ. PROPERTIES AND FUNCTIONS OF THE NOVEL TYPE I INTERFERON EPSILON. Semin Immunol 2019;43:101328. [PMID: 31734130 DOI: 10.1016/j.smim.2019.101328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
411 Chen L, Huang H, Zhang W, Ding F, Fan Z, Zeng Z. Exosomes Derived From T Regulatory Cells Suppress CD8+ Cytotoxic T Lymphocyte Proliferation and Prolong Liver Allograft Survival. Med Sci Monit 2019;25:4877-84. [PMID: 31258152 DOI: 10.12659/MSM.917058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
412 Smith U, Li Q, Rydén M, Spalding KL. Cellular senescence and its role in white adipose tissue. Int J Obes (Lond) 2021;45:934-43. [PMID: 33510393 DOI: 10.1038/s41366-021-00757-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
413 Learoyd D, Twigg S, Zedenius JV, Robinson B. The Molecular Genetics of Endocrine Tumours. Journal of Pediatric Endocrinology and Metabolism 1998;11. [DOI: 10.1515/jpem.1998.11.2.195] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
414 Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res. 2000;24:39-46. [PMID: 10634644 DOI: 10.1016/s0145-2126(99)00158-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
415 Larripa I, Giere I, Slavutsky I, Diaz M. Molecular study of the interferon genes in chronic myeloid leukemia. Leuk Res 1995;19:513-7. [PMID: 7544849 DOI: 10.1016/0145-2126(95)00010-l] [Reference Citation Analysis]
416 Aytac U, Konishi T, David H, Mendoza S, Miller CW. Rb Independent Inhibition of Cell Growth by p15INK4B. Biochemical and Biophysical Research Communications 1999;262:534-8. [DOI: 10.1006/bbrc.1999.1164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
417 Al-Khalaf HH, Colak D, Al-Saif M, Al-Bakheet A, Hendrayani SF, Al-Yousef N, Kaya N, Khabar KS, Aboussekhra A. p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1. PLoS One 2011;6:e21111. [PMID: 21799732 DOI: 10.1371/journal.pone.0021111] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
418 Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003;3:559-70. [PMID: 12894244 DOI: 10.1038/nrc1145] [Cited by in Crossref: 196] [Cited by in F6Publishing: 163] [Article Influence: 10.3] [Reference Citation Analysis]
419 Shih YC, Kerr J, Liu J, Hurst T, Khoo SK, Ward B, Wainwright B, Chenevix-Trench G. Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. Int J Cancer 1997;70:508-11. [PMID: 9052747 DOI: 10.1002/(sici)1097-0215(19970304)70:5<508::aid-ijc3>3.0.co;2-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
420 Popov N, Gil J. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 2010;5:685-90. [PMID: 20716961 DOI: 10.4161/epi.5.8.12996] [Cited by in Crossref: 147] [Cited by in F6Publishing: 137] [Article Influence: 12.3] [Reference Citation Analysis]
421 Yeung RS. Management of recurrent cutaneous melanoma. Current Problems in Cancer 1994;18:145-86. [DOI: 10.1016/0147-0272(94)90011-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
422 Nieländer I, Bug S, Richter J, Giefing M, Ignacio Martín-subero J, Siebert R. Combining array-based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms. APMIS 2007;115:1107-34. [DOI: 10.1111/j.1600-0463.2007.apm_883.xml.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
423 Guo H, Liu F, Zhao J, Chen H. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells. J Cell Biochem 2000;79:370-85. [DOI: 10.1002/1097-4644(20001201)79:3<370::aid-jcb30>3.0.co;2-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
424 Aubrey Thompson E, Ko TC, Daniel Beauchamp R. TGF-β Inhibition of Intestinal Epithelial Cell Proliferation: G1 Cyclins, Cyclin-Dependent Kinases, and Cyclin Kinase Inhibitors. In: Vedeckis WV, editor. Hormones and Cancer. Boston: Birkhäuser; 1995. pp. 43-71. [DOI: 10.1007/978-1-4612-4266-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
425 Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 2002;33:7-20. [PMID: 11823969 DOI: 10.1053/hupa.2002.30221] [Cited by in Crossref: 109] [Cited by in F6Publishing: 85] [Article Influence: 5.5] [Reference Citation Analysis]
426 Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A. Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol. 1996;16:4673-4682. [PMID: 8756624 DOI: 10.1128/mcb.16.9.4673] [Cited by in Crossref: 219] [Cited by in F6Publishing: 102] [Article Influence: 8.4] [Reference Citation Analysis]
427 Beissert S, Schwarz T. Mechanisms Involved in Ultraviolet Light-Induced Immunosuppression. Journal of Investigative Dermatology Symposium Proceedings 1999;4:61-4. [DOI: 10.1038/sj.jidsp.5640183] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 4.6] [Reference Citation Analysis]
428 Kibel AS, Faith DA, Bova GS, Isaacs WB. Mutational analysis of ETV6 in prostate carcinoma. Prostate 2002;52:305-10. [PMID: 12210491 DOI: 10.1002/pros.10112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
429 Moussa RS, Park KC, Kovacevic Z, Richardson DR. Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity. Free Radic Biol Med 2019;133:276-94. [PMID: 29572098 DOI: 10.1016/j.freeradbiomed.2018.03.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
430 Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168-174. [PMID: 10729832 DOI: 10.1016/s0168-9525(99)01971-x] [Cited by in Crossref: 1073] [Cited by in F6Publishing: 413] [Article Influence: 48.8] [Reference Citation Analysis]
431 Pavel S, Smit NP, van der Meulen H, Kolb RM, de Groot AJ, van der Velden PA, Gruis NA, Bergman W. Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case: . Melanoma Research 2003;13:171-8. [DOI: 10.1097/00008390-200304000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
432 De Pater J, Ippel P, Van Dam W, Loneus W, Engelen J. Characterization of partial trisomy 9p due to insertional translocation by chromosomal (micro)FISH: de Pater et al. Clinical Genetics 2002;62:482-7. [DOI: 10.1034/j.1399-0004.2002.620611.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
433 Fields S, Sternglanz R. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 1994;10:286-292. [PMID: 7940758 DOI: 10.1016/0168-9525(90)90012-u] [Cited by in Crossref: 421] [Cited by in F6Publishing: 166] [Article Influence: 15.0] [Reference Citation Analysis]
434 Turgut S, Ilhan M, Turan S, Karaman O, Yaylim I, Kucukhuseyin O, Tasan E. The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage. In Vivo 2017;31:357-63. [PMID: 28438863 DOI: 10.21873/invivo.11067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
435 Ohsawa N, Sakamoto M, Saito T, Kobayashi M, Hirohashi S. Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization. Journal of Hepatology 1996;25:655-62. [DOI: 10.1016/s0168-8278(96)80235-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
436 Rump A, Fleischmann P, Jung EG, Werner D, Thielmann HW. Basal cell nevus syndrome and dysplastic nevus syndrome: investigation of gene expression by differential hybridization. Arch Dermatol Res 1996;288:399-401. [PMID: 8818188 DOI: 10.1007/BF02507109] [Reference Citation Analysis]
437 Hickman ES, Bates S, Vousden KH. Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol 1997;71:3710-8. [PMID: 9094645 DOI: 10.1128/JVI.71.5.3710-3718.1997] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
438 Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002;21:6936-48. [PMID: 12362275 DOI: 10.1038/sj.onc.1205825] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
439 McCluskey LL, Chen C, Delgadillo E, Felix JC, Muderspach LI, Dubeau L. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors. Gynecol Oncol 1999;72:87-92. [PMID: 9889036 DOI: 10.1006/gyno.1998.5235] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
440 He XS, Rong YH, Su Q, Luo Q, He DM, Li YL, Chen Y. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance. World J Gastroenterol 2005; 11(15): 2218-2223 [PMID: 15818729 DOI: 10.3748/wjg.v11.i15.2218] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
441 Guney S, Jardin F, Bertrand P, Mareschal S, Parmentier F, Picquenot J, Tilly H, Bastard C. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes. Genes Chromosom Cancer 2012;51:858-67. [DOI: 10.1002/gcc.21970] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
442 Arendt T. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int J Dev Neurosci 2001;19:231-45. [PMID: 11337192 DOI: 10.1016/s0736-5748(01)00007-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
443 Hellström-lindberg E, Malcovati L. Supportive care, growth factors, and new therapies in myelodysplastic syndromes. Blood Reviews 2008;22:75-91. [DOI: 10.1016/j.blre.2007.10.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
444 Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci U S A 1998;95:3042-7. [PMID: 9501212 DOI: 10.1073/pnas.95.6.3042] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 3.0] [Reference Citation Analysis]
445 Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14ARF–MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. Blood 2000;95:3939-44. [DOI: 10.1182/blood.v95.12.3939.012k30_3939_3944] [Cited by in Crossref: 18] [Article Influence: 0.8] [Reference Citation Analysis]
446 Wassberg C, Thörn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 1996;73:255-9. [PMID: 8546916 DOI: 10.1038/bjc.1996.45] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 2.4] [Reference Citation Analysis]
447 Miyasaka K, Ohtake K, Nomura K, Kanda H, Kominami R, Miyashita N, Kitagawa T. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 1995;13:37-43. [PMID: 7766309 DOI: 10.1002/mc.2940130107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
448 Assämäki R, Sarlomo-Rikala M, Lopez-Guerrero JA, Lasota J, Andersson LC, Llombart-Bosch A, Miettinen M, Knuutila S. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors. Genes Chromosomes Cancer 2007;46:564-76. [PMID: 17330260 DOI: 10.1002/gcc.20439] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
449 Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, Ogiwara H, Sanchez-Cespedes M, Minna JD, Yokota J. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 2010;49:342-52. [PMID: 20073072 DOI: 10.1002/gcc.20746] [Cited by in Crossref: 9] [Cited by in F6Publishing: 43] [Article Influence: 0.8] [Reference Citation Analysis]
450 Ivanova TA, Golovina DA, Zavalishina LE, Volgareva GM, Katargin AN, Andreeva YY, Frank GA, Kisseljov FL, Kisseljova NP. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. BMC Cancer 2007;7:47. [PMID: 17359536 DOI: 10.1186/1471-2407-7-47] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
451 Grandér D. How do mutated oncogenes and tumor suppressor genes cause cancer? Med Oncol 1998;15:20-6. [PMID: 9643526 DOI: 10.1007/BF02787340] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
452 Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. [Genetic profile and molecular bases of pancreatic carcinogenesis]. Gastroenterol Hepatol 2007;30:592-6. [PMID: 18028855 DOI: 10.1157/13112587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
453 Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer. 1995;61:115-120. [PMID: 7705923 DOI: 10.1002/ijc.2910610120] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 3.0] [Reference Citation Analysis]
454 Steilen-gimbel H, Steudel W, Feiden W, Moringlane J, Henn W, Zang KD. Genetic Heterogeneity in Human Astrocytomas. Cancer Genetics and Cytogenetics 1999;113:115-9. [DOI: 10.1016/s0165-4608(99)00013-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
455 Shan Z, Parker T, Wiest JS. Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 2004;23:6612-20. [PMID: 15208665 DOI: 10.1038/sj.onc.1207857] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
456 Skapek SX, Qian Y, Lee EY. The retinoblastoma protein: More than meets the eyes. Progress in Retinal and Eye Research 1997;16:591-626. [DOI: 10.1016/s1350-9462(96)00033-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
457 Below JE, Cox NJ, Fukagawa NK, Hirvonen A, Testa JR. Factors that impact susceptibility to fiber-induced health effects. J Toxicol Environ Health B Crit Rev 2011;14:246-66. [PMID: 21534090 DOI: 10.1080/10937404.2011.556052] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
458 Li W, Liu D, Tang S, Li D, Han R, Tian Y, Li H, Li G, Li W, Liu X, Kang X, Li Z. A multiallelic indel in the promoter region of the Cyclin-dependent kinase inhibitor 3 gene is significantly associated with body weight and carcass traits in chickens. Poult Sci 2019;98:556-65. [PMID: 30169814 DOI: 10.3382/ps/pey404] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
459 Sacks PG. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metast Rev 1996;15:27-51. [DOI: 10.1007/bf00049486] [Cited by in Crossref: 80] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
460 Shaib W, Kono S, Saba N. Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck. J Oncol 2012;2012:521215. [PMID: 22778735 DOI: 10.1155/2012/521215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
461 Mead LJ, Gillespie MT, Hung JY, Rane US, Rayeroux KC, Irving LB, Campbell LJ. Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene. Int J Cancer 1997;71:213-7. [DOI: 10.1002/(sici)1097-0215(19970410)71:2<213::aid-ijc15>3.0.co;2-i] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
462 Li P, Yan Y, Zhang H, Cui S, Wang C, Wei W, Qian H, Wang J, Zhang Q. Biological activities of siRNA-loaded lanthanum phosphate nanoparticles on colorectal cancer. Journal of Controlled Release 2020;328:45-58. [DOI: 10.1016/j.jconrel.2020.08.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Ohsawa N, Uchino S, Saito T, Miyahara M, Inoue T, Kitano S. Prognostic significance of loss of heterozygosity on chromosome 9p21–22 in human esophageal cancer. Int J Clin Oncol 1997;2:230-4. [DOI: 10.1007/bf02488997] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
464 Collins CJ, Sedivy JM. Involvement of the INK4a/Arf gene locus in senescence. Aging Cell 2003;2:145-50. [DOI: 10.1046/j.1474-9728.2003.00048.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
465 Singh AD, Shields CL, Shields JA, De Potter P. Bilateral Primary Uveal Melanoma. Ophthalmology 1996;103:256-62. [DOI: 10.1016/s0161-6420(96)30707-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
466 Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol. 1999;155:105-113. [PMID: 10393843 DOI: 10.1016/s0002-9440(10)65105-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
467 Guney S, Bertrand P, Jardin F, Ruminy P, Pierre Kerckaert J, Tilly H, Bastard C. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large b-cell lymphomas. Genes Chromosom Cancer 2011;50:715-25. [DOI: 10.1002/gcc.20893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
468 Ohtani N, Yamakoshi K, Takahashi A, Hara E. Real-time in vivo imaging of p16gene expression: a new approach to study senescence stress signaling in living animals. Cell Div 2010;5:1. [PMID: 20157424 DOI: 10.1186/1747-1028-5-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
469 Wajed SA, Laird PW, DeMeester TR. DNA methylation: an alternative pathway to cancer. Ann Surg. 2001;234:10-20. [PMID: 11420478 DOI: 10.1097/00000658-200107000-00003,] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998;1378:F115-F177. [PMID: 9823374 DOI: 10.1016/s0304-419x(98)00017-1] [Cited by in Crossref: 118] [Cited by in F6Publishing: 220] [Article Influence: 4.9] [Reference Citation Analysis]
471 Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998;17:5001-5014. [PMID: 9724636 DOI: 10.1093/emboj/17.17.5001] [Cited by in Crossref: 726] [Cited by in F6Publishing: 746] [Article Influence: 30.3] [Reference Citation Analysis]
472 Einsiedel HG, Taube T, Beyermann B, Dragon S, Möricke A, Kebelmann-Betzig C, Köchling J, Henze G, Seeger K. Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2001;40:413-7. [PMID: 11426564 DOI: 10.3109/10428190109057941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
473 Wu D, Hiroshima K, Matsumoto S, Nabeshima K, Yusa T, Ozaki D, Fujino M, Yamakawa H, Nakatani Y, Tada Y, Shimada H, Tagawa M. Diagnostic Usefulness of p16/CDKN2A FISH in Distinguishing Between Sarcomatoid Mesothelioma and Fibrous Pleuritis. American Journal of Clinical Pathology 2013;139:39-46. [DOI: 10.1309/ajcpt94jvwihbkrd] [Cited by in Crossref: 75] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
474 Elsayed YA, Sausville EA. Selected Novel Anticancer Treatments Targeting Cell Signaling Proteins. The Oncologist 2001;6:517-37. [DOI: 10.1634/theoncologist.6-6-517] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
475 Kawana Y, Ichikawa T, Suzuki H, Ueda T, Komiya A, Ichikawa Y, Furuya Y, Akakura K, Igarashi T, Ito H. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Prostate 2002;53:60-4. [DOI: 10.1002/pros.10131] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
476 van Zutven LJ, van Drunen E, de Bont JM, Wattel MM, Den Boer ML, Pieters R, Hagemeijer A, Slater RM, Beverloo HB. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia. Leukemia. 2005;19:1281-1284. [PMID: 15843818 DOI: 10.1038/sj.leu.2403769] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
477 Radford KJ, Mallesch J, Hersey P. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 1995;62:631-5. [PMID: 7665237 DOI: 10.1002/ijc.2910620523] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 2.7] [Reference Citation Analysis]
478 Barker FG, Israel MA. The Molecular Biology of Brain Tumors. Neurologic Clinics 1995;13:701-21. [DOI: 10.1016/s0733-8619(18)30014-8] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
479 Kuo KT, Chang HC, Hsiao CH, Lin MC. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion. Br J Ophthalmol 2006;90:894-9. [PMID: 16540490 DOI: 10.1136/bjo.2005.086314] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
480 Khaled HM, Aly MS, Mokhtar N. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis. Urol Oncol 2004;22:443-7. [PMID: 15610858 DOI: 10.1016/j.urolonc.2004.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
481 Chen YW, Chu HC, Ze-Shiang Lin, Shiah WJ, Chou CP, Klimstra DS, Lewis BC. p16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One 2013;8:e69389. [PMID: 23894465 DOI: 10.1371/journal.pone.0069389] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
482 Schulze-gahmen U, Jung JU, Kim S. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure 1999;7:245-54. [DOI: 10.1016/s0969-2126(99)80035-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
483 André E, Conquet F, Steinmayr M, Stratton SC, Porciatti V, Becker-André M. Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 1998;17:3867-77. [PMID: 9670004 DOI: 10.1093/emboj/17.14.3867] [Cited by in Crossref: 144] [Cited by in F6Publishing: 137] [Article Influence: 6.0] [Reference Citation Analysis]
484 Barnes DM. Cyclin D1 in mammary carcinoma. J Pathol 1997;181:267-9. [DOI: 10.1002/(sici)1096-9896(199703)181:3<267::aid-path783>3.0.co;2-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
485 Gerstenblith MR, Goldstein AM, Tucker MA, Fraser MC. Genetic Testing for Melanoma Predisposition: Current Challenges. Cancer Nursing 2007;30:452-9. [DOI: 10.1097/01.ncc.0000300165.98391.e7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
486 Fong KM, Zimmerman PV, Smith PJ. Lung pathology: the molecular genetics of non-small cell lung cancer. Pathology 1995;27:295-301. [DOI: 10.1080/00313029500169173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
487 Ali Z, Yousaf N, Larkin J. Melanoma epidemiology, biology and prognosis. EJC Suppl 2013;11:81-91. [PMID: 26217116 DOI: 10.1016/j.ejcsup.2013.07.012] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 12.4] [Reference Citation Analysis]
488 Shah SJ, Taub JW, Witt TL, Pollock BH, Ding BC, Moore DS, Amylon M, Pullen J, Ravindranath Y, Matherly LH. Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia: p15 and p16 Gene Alterations and DHFR Expression. British Journal of Haematology 2001;113:746-56. [DOI: 10.1046/j.1365-2141.2001.02775.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
489 Ansari-lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM. Distinction of Endocervical and Endometrial Adenocarcinomas: Immunohistochemical p16 Expression Correlated With Human Papillomavirus (HPV) DNA Detection. The American Journal of Surgical Pathology 2004;28:160-7. [DOI: 10.1097/00000478-200402000-00002] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 6.9] [Reference Citation Analysis]
490 Björkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S. Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 1997;75:523-7. [PMID: 9052404 DOI: 10.1038/bjc.1997.91] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 2.4] [Reference Citation Analysis]
491 Povey S, Armour J, Farndon P, Haines JL, Knowles M, Olopade F, Pilz A, White JA, Kwiatkowski DJ. Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. Ann Hum Genet 1994;58:177-250. [PMID: 7872647 DOI: 10.1111/j.1469-1809.1994.tb01887.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 1.4] [Reference Citation Analysis]
492 Du Y, Hao X, Liu X. Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway. Oncol Lett 2018;15:4912-8. [PMID: 29541247 DOI: 10.3892/ol.2018.7910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
493 Herman JG. Epigenetic changes in cancer and preneoplasia. Cold Spring Harb Symp Quant Biol 2005;70:329-33. [PMID: 16869769 DOI: 10.1101/sqb.2005.70.036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
494 Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y. Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer. 2000;27:169-176. [PMID: 10612805 DOI: 10.1002/(SICI)1098-2264(200002)27:2%3C169::AID-GCC8%3E3.0.CO;2-M] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
495 Mao X, Jones TA, Tomlinson I, Rowan AJ, Fedorova LI, Zelenin AV, Mao JI, Gutowski NJ, Noble M, Sheer D. Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line. Br J Cancer 1999;79:724-31. [PMID: 10070860 DOI: 10.1038/sj.bjc.6690116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
496 Clark J, Edwards S, Feber A, Flohr P, John M, Giddings I, Crossland S, Stratton MR, Wooster R, Campbell C, Cooper CS. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 2003;22:1247-52. [DOI: 10.1038/sj.onc.1206247] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
497 Helou K, L� XC, Montelius-alatalo K, St�hl F, Klinga-levan K, Levan G, R�hme D. A dual-color FISH framework map for the characterization of theSai1 tumor suppression region on rat chromosome 5. Genes Chromosom Cancer 2000;27:362-72. [DOI: 10.1002/(sici)1098-2264(200004)27:4<362::aid-gcc5>3.0.co;2-1] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
498 Littooij AS, Hochstenbach R, Sinke RJ, van Tintelen P, Giltay JC. Two cases with partial trisomy 9p: Molecular cytogenetic characterization and clinical follow-up. Am J Med Genet 2002;109:125-32. [DOI: 10.1002/ajmg.10322] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
499 Nagasaki M, Zhang J, Morikawa S, Harada T, Nabika T, Tanaka Y. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation. Pathol Int 2005;55:264-72. [PMID: 15871724 DOI: 10.1111/j.1440-1827.2005.01823.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
500 Kumar R, Rozell BL, Louhelainen J, Hemminki K. Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas. Int J Cancer 1998;75:193-8. [DOI: 10.1002/(sici)1097-0215(19980119)75:2<193::aid-ijc5>3.0.co;2-p] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
501 Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf A, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Germline Mutations of the CDKN2 Gene in UK Melanoma Families. Human Molecular Genetics 1997;6:2061-7. [DOI: 10.1093/hmg/6.12.2061] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 3.8] [Reference Citation Analysis]
502 Tanaka H, Fujii Y, Hirabayashi H, Miyoshi S, Sakaguchi M, Yoon HE, Matsuda H. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers. Int J Cancer 1998;79:111-5. [PMID: 9583722 DOI: 10.1002/(sici)1097-0215(19980417)79:2<111::aid-ijc2>3.0.co;2-w] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
503 Tokino T, Urano T, Furuhata T, Matsushima M, Miyatsu T, Sasaki S, Nakamura Y. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 1996;97:625-31. [PMID: 8655143 DOI: 10.1007/BF02281873] [Cited by in Crossref: 47] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
504 Fotedar R, Fotedar A. Cell cycle control of DNA replication. In: Meijer L, Guidet S, Tung HYL, editors. Progress in Cell Cycle Research. Boston: Springer US; 1995. pp. 73-89. [DOI: 10.1007/978-1-4615-1809-9_6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
505 Petronzelli F, Sollima D, Coppola G, Martini-neri ME, Neri G, Genuardi M. CDKN2A germline splicing mutation affecting both p16ink4 and p14arf RNA processing in a melanoma/neurofibroma kindred. Genes Chromosom Cancer 2001;31:398-401. [DOI: 10.1002/gcc.1159] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
506 Min KO, Seo EJ, Kwon HJ, Lee EJ, Kim WI, Kang CS, Kim K. Methylation of p16INK4A and p57KIP2 are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006;19:141-8. [DOI: 10.1038/modpathol.3800505] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
507 Tsuda H, Yamamoto K, Inoue T, Uchiyama I, Umesaki N. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer 2000;82:675-82. [PMID: 10682682 DOI: 10.1054/bjoc.1999.0980] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 2.4] [Reference Citation Analysis]
508 Franklin DS, Xiong Y. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 1996;7:1587-99. [PMID: 8898364 DOI: 10.1091/mbc.7.10.1587] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 3.9] [Reference Citation Analysis]
509 Soberanes S, Gonzalez A, Urich D, Chiarella SE, Radigan KA, Osornio-Vargas A, Joseph J, Kalyanaraman B, Ridge KM, Chandel NS, Mutlu GM, De Vizcaya-Ruiz A, Budinger GR. Particulate matter Air Pollution induces hypermethylation of the p16 promoter Via a mitochondrial ROS-JNK-DNMT1 pathway. Sci Rep 2012;2:275. [PMID: 22355787 DOI: 10.1038/srep00275] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
510 Chim C, Kwong Y. Adverse prognostic impact of CDKN2B hyper-methylationin acute promyelocytic leukemia. Leukemia & Lymphoma 2009;47:815-25. [DOI: 10.1080/10428190500513827] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
511 Rulyak SJ, Brentnall TA, Lynch HT, Austin MA. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome. Cancer 2003;98:798-804. [DOI: 10.1002/cncr.11562] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
512 Zhang B, Peng Zy. A minimum folding unit in the ankyrin repeat protein p16(INK4). J Mol Biol 2000;299:1121-32. [PMID: 10843863 DOI: 10.1006/jmbi.2000.3803] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 2.8] [Reference Citation Analysis]
513 Geradts J, Hruban RH, Schutte M, Kern SE, Maynard R. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies. Appl Immunohistochem Mol Morphol. 2000;8:71-79. [PMID: 10937052 DOI: 10.1097/00129039-200003000-00011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 0.7] [Reference Citation Analysis]
514 Ohta M, Berd D, Shimizu M, Nagai H, Cotticelli M-G, Mastrangelo M, Shields JA, Shields CL, Croce CM, Huebner K. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer 1996;65:762-7. [PMID: 8631588 DOI: 10.1002/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X] [Cited by in Crossref: 54] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
515 Obata M, Imamura E, Yoshida Y, Goto J, Kishibe K, Yasuda A, Ogawa K. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1). Mol Carcinog 2001;32:9-18. [PMID: 11568971 DOI: 10.1002/mc.1059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
516 Fried L, Tan A, Bajaj S, Liebman TN, Polsky D, Stein JA. Technological advances for the detection of melanoma: Advances in molecular techniques. J Am Acad Dermatol 2020;83:996-1004. [PMID: 32360759 DOI: 10.1016/j.jaad.2020.03.122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
517 Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1734-1740 [PMID: 18350604 DOI: 10.3748/wjg.14.1734] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
518 Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 2005;64:398-403. [PMID: 15892297 DOI: 10.1093/jnen/64.5.398] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
519 Farrell WE, Clayton RN. Tumour suppressor genes in pituitary tumour formation. Best Practice & Research Clinical Endocrinology & Metabolism 1999;13:381-93. [DOI: 10.1053/beem.1999.0029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
520 Bito T, Ueda M, Ito A, Ichihashi M. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions. J Cutan Pathol 1997;24:305-8. [PMID: 9194584 DOI: 10.1111/j.1600-0560.1997.tb00796.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
521 van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001;69:774-9. [PMID: 11500806 DOI: 10.1086/323411] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
522 Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-7. [DOI: 10.1038/35096061] [Cited by in Crossref: 648] [Cited by in F6Publishing: 592] [Article Influence: 30.9] [Reference Citation Analysis]
523 Martínez-jiménez F, Muiños F, Sentís I, Deu-pons J, Reyes-salazar I, Arnedo-pac C, Mularoni L, Pich O, Bonet J, Kranas H, Gonzalez-perez A, Lopez-bigas N. A compendium of mutational cancer driver genes. Nat Rev Cancer 2020;20:555-72. [DOI: 10.1038/s41568-020-0290-x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 47.0] [Reference Citation Analysis]
524 Kim KS, Sack JS, Tokarski JS, Qian L, Chao ST, Leith L, Kelly YF, Misra RN, Hunt JT, Kimball SD, Humphreys WG, Wautlet BS, Mulheron JG, Webster KR. Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. J Med Chem 2000;43:4126-34. [PMID: 11063609 DOI: 10.1021/jm000231g] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
525 Lau WM, Ho TH, Hui KM. p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells. Oncogene. 2007;26:6050-6060. [PMID: 17369842 DOI: 10.1038/sj.onc.1210405] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
526 Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene 2000;19:5314-23. [PMID: 11103932 DOI: 10.1038/sj.onc.1203908] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
527 Grady B, Goharderakhshan R, Chang J, Ribeiro-filho LA, Perinchery G, Franks J, Presti J, Carroll P, Dahiya R. FREQUENTLY DELETED LOCI ON CHROMOSOME 9 MAY HARBOR SEVERAL TUMOR SUPPRESSOR GENES IN HUMAN RENAL CELL CARCINOMA. Journal of Urology 2001;166:1088-92. [DOI: 10.1016/s0022-5347(05)65927-7] [Cited by in Crossref: 28] [Article Influence: 1.3] [Reference Citation Analysis]
528 Kumamoto H, Ooya K. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas. J Oral Pathol Med 2006;35:183-9. [DOI: 10.1111/j.1600-0714.2006.00381.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
529 Sakaguchi M, Fujii Y, Hirabayashi H, Yoon H, Komoto Y, Oue T, Kusafuka T, Okada A, Matsuda H. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study. Int J Cancer 1996;65:442-5. [DOI: 10.1002/(sici)1097-0215(19960208)65:4<442::aid-ijc8>3.0.co;2-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
530 Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med. 1997;3:313-319. [PMID: 9055859 DOI: 10.1038/nm0397-313] [Cited by in Crossref: 150] [Cited by in F6Publishing: 140] [Article Influence: 6.0] [Reference Citation Analysis]
531 Qari MH, Khalil SH, Kambouris M, Meyer BF. Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia: Mutation of p16, p21 and CDK4 Genes in ALL. British Journal of Haematology 1998;103:467-72. [DOI: 10.1046/j.1365-2141.1998.00974.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
532 Yang B, Guo Z, Huang Y, Zhu S. Codon optimization of MTS1 and its expression in Escherichia coli. Protein Expression and Purification 2004;36:307-11. [DOI: 10.1016/j.pep.2004.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
533 Hu X, Zuckerman KS. Cell Cycle and Transcriptional Control of Human Myeloid Leukemic Cells by Transforming Growth Factor Beta. Leukemia & Lymphoma 2009;38:235-46. [DOI: 10.3109/10428190009087015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
534 Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC. Mutations associated with familial melanoma impair p16INK4 function. Nat Genet 1995;10:114-6. [PMID: 7647780 DOI: 10.1038/ng0595-114] [Cited by in Crossref: 199] [Cited by in F6Publishing: 181] [Article Influence: 7.4] [Reference Citation Analysis]
535 Beijersbergen RL, Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996;1287:103-20. [PMID: 8672526 DOI: 10.1016/0304-419x(96)00002-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 42] [Article Influence: 0.8] [Reference Citation Analysis]
536 Kashiwabara K, Oyama T, Sano T, Fukuda T, Nakajima T. Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers. Int J Cancer 1998;79:215-20. [PMID: 9645340 DOI: 10.1002/(sici)1097-0215(19980619)79:3<215::aid-ijc1>3.0.co;2-s] [Cited by in Crossref: 53] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
537 Dreyer MK, Borcherding DR, Dumont JA, Peet NP, Tsay JT, Wright PS, Bitonti AJ, Shen J, Kim SH. Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717. J Med Chem 2001;44:524-30. [PMID: 11170642 DOI: 10.1021/jm001043t] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
538 Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235-246. [PMID: 14744434 DOI: 10.1016/s0092-8674(03)01075-4] [Cited by in Crossref: 624] [Cited by in F6Publishing: 262] [Article Influence: 34.7] [Reference Citation Analysis]
539 Albino AP, Fountain JW. Oncogenes and Tumor Suppressor Genes in Cutaneous Malignant Melanoma. Photochem Photobiol 1996;63:412-8. [DOI: 10.1111/j.1751-1097.1996.tb03058.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
540 Lang JC, Tobin EJ, Knobloch TJ, Schuller DE, Bartynski KJ, Mountain RE, Nicholson R, DeYoung BR, Weghorst CM. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope. 1998;108:923-928. [PMID: 9628511 DOI: 10.1097/00005537-199806000-00024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
541 Mao X, Li B, Liang Y, Li S, Zhou J, He Q, Jiang N, Chen Y, Sun Y, Cui Y, Jiang W, Wang H, Wang L, Ke Z. Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncol Lett 2018;15:6533-40. [PMID: 29731855 DOI: 10.3892/ol.2018.8137] [Reference Citation Analysis]
542 Riede I. Three mutant genes cooperatively induce brain tumor formation in Drosophila malignant brain tumor. Cancer Genet Cytogenet 1996;90:135-41. [PMID: 8830723 DOI: 10.1016/s0165-4608(96)00093-3] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
543 Ahamed S, Foster JS, Bukovsky A, Diehl JA, Wimalasena J. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells. Mol Carcinog 2002;34:45-58. [PMID: 12112322 DOI: 10.1002/mc.10048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
544 Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mol Cell Biol 1999;19:3916-28. [PMID: 10207115 DOI: 10.1128/MCB.19.5.3916] [Cited by in Crossref: 84] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
545 Kannan K, Sharpless NE, Xu J, O'Hagan RC, Bosenberg M, Chin L. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model. Proc Natl Acad Sci U S A 2003;100:1221-5. [PMID: 12538879 DOI: 10.1073/pnas.0336397100] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
546 Tan DS, Kaye S. Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol 2007;60:355-60. [PMID: 17018684 DOI: 10.1136/jcp.2006.040030] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
547 Liu J, Liao X, Gu Y, Fu L, Zhao J, Li L, Chen Z, Jiang J. Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma. J Thorac Dis 2018;10:5522-30. [PMID: 30416802 DOI: 10.21037/jtd.2018.08.59] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
548 Masuda A, Osada H, Yatabe Y, Kozaki K, Tatematsu Y, Takahashi T, Hida T, Takahashi T, Takahashi T. Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Am J Pathol 2001;158:87-96. [PMID: 11141482 DOI: 10.1016/s0002-9440(10)63947-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
549 Hilgers W, Rosty C, Hahn SA. Molecular pathogenesis of pancreatic cancer. Hematol Oncol Clin North Am. 2002;16:17-35. [PMID: 12063826 DOI: 10.1016/s0889-8588(01)00005-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
550 Takita J, Hayashi Y, Yokota J. Loss of heterozygosity in Neuroblastomas—an Overview. European Journal of Cancer 1997;33:1971-3. [DOI: 10.1016/s0959-8049(97)00292-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
551 Shapiro GI, Rollins BJ. p16INK4A as a human tumor suppressor. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1996;1242:165-9. [DOI: 10.1016/0304-419x(95)00011-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
552 Baccichet A, Qualman SK, Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leukemia Research 1997;21:817-23. [DOI: 10.1016/s0145-2126(97)00075-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
553 Komuro H, Valentine MB, Rubnitz JE, Saito M, Raimondi SC, Carroll AJ, Yi T, Sherr CJ, Look AT. p27KIP1 deletions in childhood acute lymphoblastic leukemia. Neoplasia 1999;1:253-61. [PMID: 10935480 DOI: 10.1038/sj.neo.7900033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
554 Newton Bishop, Harland, Bishop. The genetics of melanoma: the UK experience: GENETICS OF MELANOMA. Clinical and Experimental Dermatology 1998;23:158-61. [DOI: 10.1046/j.1365-2230.1998.00344.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
555 Jefferies S, Edwards SM, Hamoudi RA, A'Hern R, Foulkes W, Goldgar D, Eeles R; MPT Collaborators. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours. Br J Cancer 2001;85:1383-6. [PMID: 11720478 DOI: 10.1054/bjoc.2001.2068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
556 Yang C, Xiong W, Qiu Q, Tahiri H, Superstein R, Carret AS, Sapieha P, Hardy P. Anti-proliferative and anti-tumour effects of lymphocyte-derived microparticles are neither species- nor tumour-type specific. J Extracell Vesicles 2014;3. [PMID: 24834146 DOI: 10.3402/jev.v3.23034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
557 Maeurer MJ, Lotze MT. Tumor Recognition by the Cellular Immune System: New Aspects of Tumor Immunology. International Reviews of Immunology 2009;14:97-132. [DOI: 10.3109/08830189709116848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
558 Gamieldien W, Victor TC, Mugwanya D, Stepien A, Gelderblom WCA, Marasas WFO, Geiger DH, van Helden PD. p53 andp16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa. Int J Cancer 1998;78:544-9. [DOI: 10.1002/(sici)1097-0215(19981123)78:5<544::aid-ijc3>3.0.co;2-t] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
559 Fearfield LA, Larkin JM, Rowe A, A'Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore ME, Bunker CB. Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. Br J Dermatol 2007;156:440-7. [PMID: 17300231 DOI: 10.1111/j.1365-2133.2006.07581.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
560 Hirabayashi H, Fujii Y, Sakaguchi M, Tanaka H, Yoon H, Komoto Y, Inoue M, Miyoshi S, Matsuda H. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation ofCDKN2 gene in thymoma and thymic carcinoma. Int J Cancer 1997;73:639-44. [DOI: 10.1002/(sici)1097-0215(19971127)73:5<639::aid-ijc5>3.0.co;2-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
561 Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 1998;396:177-180. [PMID: 9823898 DOI: 10.1038/24179] [Cited by in Crossref: 525] [Cited by in F6Publishing: 517] [Article Influence: 21.9] [Reference Citation Analysis]
562 Franchi A, Alos L, Gale N, Massi D, Paglierani M, Santucci M, Zidar N, Cardesa A. Expression of p16 in sinonasal malignant melanoma. Virchows Arch 2006;449:667-72. [DOI: 10.1007/s00428-006-0288-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
563 Tyagi E, Liu B, Li C, Liu T, Rutter J, Grossman D. Loss of p16INK4A stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway. Oncotarget 2017;8:55848-62. [PMID: 28915557 DOI: 10.18632/oncotarget.19862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
564 Zhao X, Song T, He Z, Tang L, Zhu Y. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma. Med Oncol 2010;27:985-91. [PMID: 19806481 DOI: 10.1007/s12032-009-9320-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
565 Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P, Dejean A. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Hepatology 2003;37:852-61. [PMID: 12668978 DOI: 10.1053/jhep.2003.50138] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
566 Chang Z, Huang D, Hu S. NF-Y-mediatedTrans-activation of the human thymidine kinase promoter is closely linked to activation of cyclin-dependent kinase. J Cell Biochem 1999;75:300-9. [DOI: 10.1002/(sici)1097-4644(19991101)75:2<300::aid-jcb12>3.0.co;2-z] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
567 Yin JG, Liu XY, Wang B, Wang DY, Wei M, Fang H, Xiang M. Gene expression profiling analysis of ovarian cancer. Oncol Lett 2016;12:405-12. [PMID: 27347159 DOI: 10.3892/ol.2016.4663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
568 Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, Howley PM. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA. 1996;93:4350-4354. [PMID: 8633069 DOI: 10.1073/pnas.93.9.4350] [Cited by in Crossref: 242] [Cited by in F6Publishing: 234] [Article Influence: 9.3] [Reference Citation Analysis]
569 Phelps DE, Hsiao KM, Li Y, Hu N, Franklin DS, Westphal E, Lee EY, Xiong Y. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol Cell Biol 1998;18:2334-43. [PMID: 9528803 DOI: 10.1128/MCB.18.4.2334] [Cited by in Crossref: 62] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
570 Wong Y, Chung T, Cheung T, Nobori T, Yim S, Lai K, Yu A, Diccianni M, Li T, Chang A. p16INK4andp15INK4BAlterations in Primary Gynecologic Malignancy. Gynecologic Oncology 1997;65:319-24. [DOI: 10.1006/gyno.1997.4669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
571 Tchougounova E, Jiang Y, Bråsäter D, Lindberg N, Kastemar M, Asplund A, Westermark B, Uhrbom L. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene 2009;28:1537-48. [PMID: 19219070 DOI: 10.1038/onc.2009.9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
572 Noguchi R, Yamaguchi K, Ikenoue T, Terakado Y, Ohta Y, Yamashita N, Kainuma O, Yokoi S, Maru Y, Nagase H, Furukawa Y. Genetic alterations in Japanese extrahepatic biliary tract cancer. Oncol Lett 2017;14:877-84. [PMID: 28693246 DOI: 10.3892/ol.2017.6224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
573 Greenberger JS. The pathophysiology and management of spine metastasis from lung cancer. J Neurooncol 1995;23:109-20. [PMID: 7543939 DOI: 10.1007/BF01053416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
574 Martin E, Cacheux V, Cavé H, Lapierre JM, Le Paslier D, Grandchamp B. Localization of the CDKN4/p27Kip1 gene to human chromosome 12p12.3. Hum Genet 1995;96:668-70. [PMID: 8522324 DOI: 10.1007/BF00210296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
575 Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC, Bast RC Jr. Pathogenesis of ovarian cancers. J Soc Gynecol Investig 1994;1:181-90. [PMID: 9419769 DOI: 10.1177/107155769400100302] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
576 Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908-14. [DOI: 10.1038/sj.onc.1205834] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
577 Ward KA, Lazovich D, Hordinsky MK. Germline melanoma susceptibility and prognostic genes: A review of the literature. Journal of the American Academy of Dermatology 2012;67:1055-67. [DOI: 10.1016/j.jaad.2012.02.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
578 Iolascon A, Giordani L, Moretti A, Basso G, Borriello A, Della Ragione F. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma. Hepatology 1998;27:989-95. [DOI: 10.1002/hep.510270414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
579 Zhou C, Li J, Li Q. CDKN2A methylation in esophageal cancer: a meta-analysis. Oncotarget. 2017;8:50071-50083. [PMID: 28637022 DOI: 10.18632/oncotarget.18412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
580 Al-Mohanna MA, Al-Khalaf HH, Al-Yousef N, Aboussekhra A. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light. Nucleic Acids Res 2007;35:223-33. [PMID: 17158160 DOI: 10.1093/nar/gkl1075] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.0] [Reference Citation Analysis]
581 Zen K, Yasui K, Gen Y, Dohi O, Wakabayashi N, Mitsufuji S, Itoh Y, Zen Y, Nakanuma Y, Taniwaki M. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma. Oncogene. 2009;28:2910-2918. [PMID: 19503097 DOI: 10.1038/onc.2009.148] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
582 Stewart CL, Soria AM, Hamel PA. Integration of the pRB and p53 cell cycle control pathways. J Neurooncol 2001;51:183-204. [PMID: 11407592 DOI: 10.1023/a:1010615822317] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
583 Salvesen HB, Kumar R, Stefansson I, Angelini S, Macdonald N, Smeds J, Jacobs IJ, Hemminki K, Das S, Akslen LA. Low frequency of BRAF and CDKN2A mutations in endometrial cancer. Int J Cancer 2005;115:930-4. [DOI: 10.1002/ijc.20702] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
584 Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, Jablons DM. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. J Natl Cancer Inst 2000;92:636-41. [PMID: 10772681 DOI: 10.1093/jnci/92.8.636] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 4.2] [Reference Citation Analysis]
585 Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, Mcmahon M, Oren M, Mccormick F. Opposing Effects of Ras on p53. Cell 2000;103:321-30. [DOI: 10.1016/s0092-8674(00)00123-9] [Cited by in Crossref: 255] [Cited by in F6Publishing: 112] [Article Influence: 11.6] [Reference Citation Analysis]
586 Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, McCarthy SW, Scolyer RA. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287-301. [PMID: 16916716 DOI: 10.1080/00313020600817951] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
587 Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, van Kessel AG, Suijkerbuijk R. Frequent Loss of 9p21 (p16INK4A) and Other Genomic Imbalances in Human Malignant Fibrous Histiocytoma. Cancer Genetics and Cytogenetics 2000;118:89-98. [DOI: 10.1016/s0165-4608(99)00178-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
588 Lindström MS, Wiman KG. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene 2003;22:4993-5005. [PMID: 12902982 DOI: 10.1038/sj.onc.1206659] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
589 Bertelsen AH, Beaudry GA, Stoller TJ, Trotta PP, Sherman MI. Tumor Suppressor Genes: Prospects for Cancer Therapies. Nat Biotechnol 1995;13:127-31. [DOI: 10.1038/nbt0295-127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
590 Ritland SR, Ganju V, Jenkins DB. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer 1995;12:277-82. [DOI: 10.1002/gcc.2870120407] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 2.3] [Reference Citation Analysis]
591 Ahmed FE. Applications of molecular biology to biomedicine and toxicology. Journal of Environmental Science and Health, Part C 1995;13:1-51. [DOI: 10.1080/10590509509373469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
592 Shi Y, Zou M, Farid NR, al-Sedairy ST. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br J Cancer 1996;74:1336-41. [PMID: 8912526 DOI: 10.1038/bjc.1996.546] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
593 Hulur I, Skol AD, Gamazon ER, Cox NJ, Onel K. Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma. PLoS One 2017;12:e0185730. [PMID: 28973033 DOI: 10.1371/journal.pone.0185730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
594 Wainwright B. Familial melanoma and p16--a hung jury. Nat Genet 1994;8:3-5. [PMID: 7987389 DOI: 10.1038/ng0994-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
595 Kim M, Katayose Y, Rojanala L, Shah S, Sgagias M, Jang L, Jung YJ, Lee SH, Hwang SG, Cowan KH. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein. Cell Death Differ 2000;7:706-11. [PMID: 10918444 DOI: 10.1038/sj.cdd.4400703] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
596 Approved by the Commission in May 1997. Genetic susceptibility to cancer: ICRP Publication 79. Ann ICRP 1998;28:1-157. [DOI: 10.1016/s0146-6435(98)00007-3] [Cited by in Crossref: 26] [Article Influence: 4.3] [Reference Citation Analysis]
597 Dannenberg JH, te Riele HP. The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis. Results Probl Cell Differ 2006;42:183-225. [PMID: 16903212 DOI: 10.1007/400_002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
598 Guo Y, Wang J, Li H, Liu W, Chen D, Zhao K, Liang X, Zhang Q, Yang Y, Chen G. Mediator subunit 23 overexpression as a novel target for suppressing proliferation and tumorigenesis in hepatocellular carcinoma. J Gastroenterol Hepatol 2015;30:1094-103. [PMID: 25684393 DOI: 10.1111/jgh.12923] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
599 Zhang L, Cheng X, Li Y, Poh C, Zeng T, Priddy R, Lovas J, Freedman P, Daley T, Rosin MP. High Frequency of Allelic Loss in Dysplastic Lichenoid Lesions. Lab Invest 2000;80:233-7. [DOI: 10.1038/labinvest.3780026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
600 Westermark B. Glioblastoma--a moving target. Ups J Med Sci 2012;117:251-6. [PMID: 22512247 DOI: 10.3109/03009734.2012.676574] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
601 Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg. 1997;84:1651-1664. [PMID: 9448610 DOI: 10.1002/bjs.1800841206] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
602 Collinet P, Vereecque R, Sabban F, Vinatier D, Leblanc E, Narducci F, Querleu D, Quesnel B. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. J Obstet Gynaecol Res 2006;32:449-53. [PMID: 16984510 DOI: 10.1111/j.1447-0756.2006.00435.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
603 Herman JG. p16(INK4): involvement early and often in gastrointestinal malignancies. Gastroenterology 1999;116:483-5. [PMID: 9922330 DOI: 10.1016/s0016-5085(99)70146-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
604 Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C, Bockaert J, Theillet C, Spengler D, Journot L. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene. 1999;18:3979-3988. [PMID: 10435621 DOI: 10.1038/sj.onc.1202933] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.0] [Reference Citation Analysis]
605 Slovak ML, Zhang F, Tcheurekdjian L, Bobadilla D, Bedell V, Arber DA, Persons DL, Sosman JA, Murata-collins JL. Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization. Cancer Detection and Prevention 2002;26:171-9. [DOI: 10.1016/s0361-090x(02)00063-6] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
606 Weber BL. Cancer genomics. Cancer Cell 2002;1:37-47. [DOI: 10.1016/s1535-6108(02)00026-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
607 Huang GW, Mo WN, Kuang GQ, Nong HT, Wei MY, Sunagawa M, Kosugi T. Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma. Laryngoscope 2001;111:1465-71. [PMID: 11568585 DOI: 10.1097/00005537-200108000-00025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
608 Han S, Ahn SH, Park K, Bae BN, Kim KH, Kim HJ, Kim YD, Kim HY. P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. Breast Cancer Res Treat 2001;70:205-12. [PMID: 11804184 DOI: 10.1023/a:1013047413895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
609 Hori Y, Hori H, Yamada Y, Carrera CJ, Tomonaga M, Kamihira S, Carson DA, Nobori T. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia. Int J Cancer 1998;75:51-6. [DOI: 10.1002/(sici)1097-0215(19980105)75:1<51::aid-ijc9>3.0.co;2-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
610 Jares P, Nadal, A, Fern�ndez PL, Pinyol M, Hern�ndez L, Cazorla M, Hern�ndez S, Be� S, Cardesa A, Campo E. Disregulation of p16MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous-cell carcinoma of the larynx. Int J Cancer 1999;81:705-11. [DOI: 10.1002/(sici)1097-0215(19990531)81:5<705::aid-ijc6>3.0.co;2-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
611 Walker DG, Lavin MF. The molecular genetics of astrocytomas: current understanding and future applications. Journal of Clinical Neuroscience 1997;4:114-21. [DOI: 10.1016/s0967-5868(97)90060-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
612 Larsen C. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDK2 locus to human malignancies. In: Meijer L, Guidet S, Philippe M, editors. Progress in Cell Cycle Research. Boston: Springer US; 1997. pp. 109-24. [DOI: 10.1007/978-1-4615-5371-7_9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
613 Soucek T, Pusch O, Hengstschläger-ottnad E, Wawra E, Bernaschek G, Hengstschläger M. Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle. FEBS Letters 1995;373:164-9. [DOI: 10.1016/0014-5793(95)01033-b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
614 Mellgren G, Vintermyr OK, Døskeland SO. Okadaic acid, cAMP, and selected nutrients inhibit hepatocyte proliferation at different stages in G1: modulation of the cAMP effect by phosphatase inhibitors and nutrients. J Cell Physiol 1995;163:232-40. [PMID: 7706367 DOI: 10.1002/jcp.1041630203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
615 Okuda M, Minehata K, Setoguchi A, Cho KW, Nakamura N, Nishigaki K, Watari T, Cevario S, O'Brien SJ, Tsujimoto H, Hasegawa A. Cloning and chromosome mapping of the feline genes p21WAF1 and p27Kip1. Gene 1997;198:141-7. [PMID: 9370275 DOI: 10.1016/s0378-1119(97)00304-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
616 Semczuk A, Jakowicki JA. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett 2004;203:1-12. [PMID: 14670612 DOI: 10.1016/j.canlet.2003.09.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
617 Tahara H, Smith AP, Gaz RD, Zariwala M, Xiong Y, Arnold A. Parathyroid Tumor Suppressor on 1p: Analysis of the p18 Cyclin-Dependent Kinase Inhibitor Gene As a Candidate. J Bone Miner Res 1997;12:1330-4. [DOI: 10.1359/jbmr.1997.12.9.1330] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
618 Zhao Y, Zhang S, Fu B, Xiao C. Abnormalities of Tumor Suppressor Genes P16 and P15 in Primary Maxillofacial Squamous Cell Carcinomas. Cancer Genetics and Cytogenetics 1999;112:26-33. [DOI: 10.1016/s0165-4608(98)00259-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
619 Beckedorff FC, Amaral MS, Deocesano-Pereira C, Verjovski-Almeida S. Long non-coding RNAs and their implications in cancer epigenetics. Biosci Rep. 2013;33:e00061. [PMID: 23875687 DOI: 10.1042/bsr20130054] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
620 Zhang L, Liu J, Lin H, Hu Q, Liu A, Hu Y. Expression of survivin, CDK4, Ki-67 and clinical significance in pediatric acute leukemia. J Huazhong Univ Sc Technol 2006;26:552-4. [DOI: 10.1007/s11596-006-0517-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
621 Jeffrey PD, Tong L, Pavletich NP. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev 2000;14:3115-25. [PMID: 11124804 DOI: 10.1101/gad.851100] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 6.8] [Reference Citation Analysis]
622 Dwivedi PP, Mallya S, Dongari-Bagtzoglou A. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med Mycol 2009;47:157-67. [PMID: 18608888 DOI: 10.1080/13693780802165797] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
623 Johnson JL, Pillai S, Chellappan SP. Genetic and biochemical alterations in non-small cell lung cancer. Biochem Res Int 2012;2012:940405. [PMID: 22928112 DOI: 10.1155/2012/940405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
624 Griniatsos J, Michail OP, Theocharis S, Arvelakis A, Papaconstantinou I, Felekouras E, Pikoulis E, Karavokyros I, Bakoyiannis C, Marinos G, Bramis J, Michail PO. Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa. World J Gastroenterol 2006; 12(13): 2109-2114 [PMID: 16610066 DOI: 10.3748/wjg.v12.i13.2109] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
625 Zhai X, Xue Q, Liu Q, Guo Y, Chen Z. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma. Mol Med Rep 2017;16:3253-61. [PMID: 28713927 DOI: 10.3892/mmr.2017.7003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
626 Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki K, Amagasa T, Inazawa J. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 2007;26:7921-32. [DOI: 10.1038/sj.onc.1210589] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
627 Wang L, Zhan X, Shen X, Li M, Yang J, Yu W, Chen H, Jin B, Mao Z. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. Mol Cell Biochem 2018;446:137-48. [PMID: 29388151 DOI: 10.1007/s11010-018-3281-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
628 Zhou M, Gu L, Yeager AM, Findley HW. Incidence and Clinical Significance of CDKN2/MTS1/P16 ink4A ND MTS2/P15 ink4B Gene Deletions in Childhood Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology 2009;14:141-50. [DOI: 10.3109/08880019709030900] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
629 Cho JW, Jeong YW, Han SW, Park JB, Jang BC, Baek WK, Kwon TK, Park JW, Kim SP, Suh MH, Suh SI. Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression. Liver Int 2003;23:194-200. [PMID: 12955883 DOI: 10.1034/j.1600-0676.2003.00821.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
630 Leone G, Voso MT, Teofili L, Lübbert M. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. Clin Immunol. 2003;109:89-102. [PMID: 14585280 DOI: 10.1016/s1521-6616(03)00207-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
631 Yeudall WA, Jakus J. Cyclin kinase inhibitors add a new dimension to cell cycle control. Eur J Cancer B Oral Oncol 1995;31B:291-8. [PMID: 8704644 DOI: 10.1016/0964-1955(95)00028-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
632 Burt EC, James LA, Greaves MJ, Birch JM, Boyle JM, Varley JM. Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts. Br J Cancer 2000;83:467-72. [PMID: 10945493 DOI: 10.1054/bjoc.2000.1292] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
633 Funk JO, Schiller PI, Barrett MT, Wong DJ, Kind P, Sander CA. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 1998;25:291-6. [DOI: 10.1111/j.1600-0560.1998.tb01748.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
634 Ryu B, Song J, Sohn T, Hruban RH, Kern SE. Frequent Germline Deletion Polymorphism of Chromosomal Region 8p12–p21 Identified as a Recurrent Homozygous Deletion in Human Tumors. Genomics 2001;72:108-12. [DOI: 10.1006/geno.2000.6449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
635 El-Ghobashy AA, Shaaban AM, Herod J, Innes J, Prime W, Herrington CS. Overexpression of cyclins A and B as markers of neoplastic glandular lesions of the cervix. Gynecol Oncol 2004;92:628-34. [PMID: 14766257 DOI: 10.1016/j.ygyno.2003.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
636 Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers. Jpn J Cancer Res 2002;93:1107-13. [PMID: 12417040 DOI: 10.1111/j.1349-7006.2002.tb01212.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
637 Yang X, Nakao Y, Pater MM, Tang S, Pater A. Expression of cellular genes in HPV16-immortalized and cigarette smoke condensate-transformed human endocervical cells. J Cell Biochem 1997;66:309-21. [DOI: 10.1002/(sici)1097-4644(19970901)66:3<309::aid-jcb4>3.0.co;2-t] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
638 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
639 Saridaki Z, Liloglou T, Zafiropoulos A, Koumantaki E, Zoras O, Spandidos DA. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 2003;148:638-48. [PMID: 12752119 DOI: 10.1046/j.1365-2133.2003.05230.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
640 Nishiyama H, Hornigold N, Davies AM, Knowles MA. A sequence-ready 840-kb PAC contig spanning the candidate tumor suppressor locus DBC1 on human chromosome 9q32-q33. Genomics 1999;59:335-8. [PMID: 10444335 DOI: 10.1006/geno.1999.5891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
641 Talve LAI, Collan YUI, Ekfors TO. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 1996;23:335-43. [DOI: 10.1111/j.1600-0560.1996.tb01307.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
642 Jin S, Fu Y, Hu Y, Fu H, Jiang S, Xiong Y, Qiao H, Zhang W, Gong Y, Wu Y. Identification of candidate genes from androgenic gland in Macrobrachium nipponense regulated by eyestalk ablation. Sci Rep 2021;11:19855. [PMID: 34615913 DOI: 10.1038/s41598-021-99022-4] [Reference Citation Analysis]
643 Hengstschläger M, Pusch O, Hengstschläger-ottnad E, Ambros PF, Bernaschek G, Wawra E. Loss of the p16/MTS1 Tumor Suppressor Gene Causes E2F-Mediated Deregulation of Essential Enzymes of the DNA Precursor Metabolism. DNA and Cell Biology 1996;15:41-51. [DOI: 10.1089/dna.1996.15.41] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
644 Haluska FG, Thiele C, Goldstein A, Tsao H, Benoit EP, Housman D. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines. Int J Cancer 1997;72:337-9. [DOI: 10.1002/(sici)1097-0215(19970717)72:2<337::aid-ijc22>3.0.co;2-b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Haber DA. Splicing into Senescence: The Curious Case of p16 and p19ARF. Cell 1997;91:555-8. [DOI: 10.1016/s0092-8674(00)80441-9] [Cited by in Crossref: 97] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
646 Tascilar M, Caspers E, Sturm P, Goggins M, Hruban R, Offerhaus G. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Annals of Oncology 1999;10:S107-10. [DOI: 10.1093/annonc/10.suppl_4.s107] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
647 Zhang S, Chen H, Yue D, Blackwell TS, Lv C, Song X. Long non-coding RNAs: Promising new targets in pulmonary fibrosis. J Gene Med 2021;23:e3318. [PMID: 33533071 DOI: 10.1002/jgm.3318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
648 Jefferies S, Foulkes W. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncology 2001;37:115-26. [DOI: 10.1016/s1368-8375(00)00065-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
649 Sanz-Ortega J, Bryant B, Sanz-Esponera J, Asenjo JA, Saez MC, Torres A, Balibrea JL, Sobel ME, Merino MJ. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer. Pathol Res Pract 1999;195:677-80. [PMID: 10549031 DOI: 10.1016/S0344-0338(99)80058-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
650 Seregni E, Ferrari L, Martinetti A, Bombardieri E. Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol 2001;20:147-66. [PMID: 11398208 DOI: 10.1002/ssu.1028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
651 Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 1997;40:137-206. [PMID: 9217926 DOI: 10.1016/s1054-3589(08)60140-4] [Cited by in Crossref: 138] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
652 Beatty BG, Qi S, Pienkowska M, Herbrick J, Scheidl T, Zhang ZM, Kola I, Scherer SW, Seth A. Chromosomal Localization of Phospholipase A2 Activating Protein, an Ets2 Target Gene, to 9p21. Genomics 1999;62:529-32. [DOI: 10.1006/geno.1999.5999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
653 Bai F, Pei XH, Godfrey VL, Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 2003;23:1269-77. [PMID: 12556487 DOI: 10.1128/MCB.23.4.1269-1277.2003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
654 Balázs M, Ádám Z, Bégány Á, Takruri AT, Ádány R. Involvement of Chromosome Losses in the Progression and Metastasis Formation of a Human Malignant Melanoma. Cancer Genetics and Cytogenetics 1999;109:114-8. [DOI: 10.1016/s0165-4608(98)00159-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
655 Tsao H. Update on familial cancer syndromes and the skin. Journal of the American Academy of Dermatology 2000;42:939-69. [DOI: 10.1067/mjd.2000.104681] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
656 Wang JC, Chen C. P16 gene deletions and point mutations in patients with agnogenic myeloid metaplasia (AMM). Leukemia Research 1999;23:631-5. [DOI: 10.1016/s0145-2126(99)00080-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
657 Moriichi K, Fujiya M, Kobayashi Y, Murakami Y, Iwama T, Kunogi T, Sasaki T, Ijiri M, Takahashi K, Tanaka K, Sakatani A, Ando K, Nomura Y, Ueno N, Kashima S, Ikuta K, Tanabe H, Mizukami Y, Saitoh Y, Okumura T. Autofluorescence Imaging Reflects the Nuclear Enlargement of Tumor Cells as well as the Cell Proliferation Ability and Aberrant Status of the p53, Ki-67, and p16 Genes in Colon Neoplasms. Molecules 2019;24:E1106. [PMID: 30897785 DOI: 10.3390/molecules24061106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
658 Rübben A, Babilas P, Baron JM, Hofheinz A, Neis M, Sels F, Sporkert M. Analysis of Tumor Cell Evolution in a Melanoma: Evidence of Mutational and Selective Pressure for Loss of p16ink4 and for Microsatellite Instability. Journal of Investigative Dermatology 2000;114:14-20. [DOI: 10.1046/j.1523-1747.2000.00838.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
659 Massague J, Polyak K. Mammalian anti proliferative signals and their targets. Current Opinion in Genetics & Development 1995;5:91-6. [DOI: 10.1016/s0959-437x(95)90059-4] [Cited by in Crossref: 96] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
660 Tsai KY, Tsao H. Primer on the human genome. Journal of the American Academy of Dermatology 2007;56:719-35. [DOI: 10.1016/j.jaad.2006.10.985] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
661 Morgan R, Newcomb P, Bailey M, Hardwick R, Alderson D. Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma. European Journal of Surgical Oncology (EJSO) 1998;24:34-7. [DOI: 10.1016/s0748-7983(98)80122-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
662 Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Cancer Prev Res (Phila). 2011;4:1961-1972. [PMID: 21881028 DOI: 10.1158/1940-6207.capr-10-0280] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
663 Child FJ, Scarisbrick JJ, Calonje E, Orchard G, Russell-Jones R, Whittaker SJ. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma. J Invest Dermatol 2002;118:941-8. [PMID: 12060387 DOI: 10.1046/j.1523-1747.2002.01785.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
664 Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA Jr, Goodfellow PJ. Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes Cancer. 1995;14:189-195. [PMID: 8589035 DOI: 10.1002/gcc.2870140306] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 2.1] [Reference Citation Analysis]
665 Zhang Y, Liu J, Xue F, Li J. p16 tumor suppressor therapy in salivary adenoid cystic carcinoma cell line SACC83. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2005;100:70-4. [DOI: 10.1016/j.tripleo.2004.11.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
666 Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, Rimm DL, Frisch SM. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 2011;31:4036-51. [PMID: 21746881 DOI: 10.1128/MCB.01342-10] [Cited by in Crossref: 90] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
667 Farrell WE, Clayton RN. Molecular Pathogenesis of Pituitary Tumors. Frontiers in Neuroendocrinology 2000;21:174-98. [DOI: 10.1006/frne.1999.0195] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
668 Park W, Vortmeyer AO, Pack S, Duray PH, Boni R, Guerami AA, Emmert-buck MR, Liotta LA, Zhuang Z. Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. Human Pathology 1998;29:127-30. [DOI: 10.1016/s0046-8177(98)90221-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
669 Suzuki H, Sugimura H, Hashimoto K. p16INK4A in Oral Squamous Cell Carcinomas—A Correlation With Biological Behaviors: Immunohistochemical and FISH Analysis. Journal of Oral and Maxillofacial Surgery 2006;64:1617-23. [DOI: 10.1016/j.joms.2005.11.097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
670 Geffrotin C, Crechet F, Le Roy P, Le Chalony C, Leplat JJ, Iannuccelli N, Barbosa A, Renard C, Gruand J, Milan D, Horak V, Tricaud Y, Bouet S, Franck M, Frelat G, Vincent-Naulleau S. Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer 2004;110:39-50. [PMID: 15054867 DOI: 10.1002/ijc.20053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
671 Platz A, Ringborg U, Lagerlöf B, Lundqvist E, Sevigny P, Inganäs M. Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma. Br J Cancer 1996;73:344-8. [PMID: 8562340 DOI: 10.1038/bjc.1996.59] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
672 Kanao H, Enomoto T, Ueda Y, Fujita M, Nakashima R, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Kimura T. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Cancer Lett. 2004;213:31-37. [PMID: 15312681 DOI: 10.1016/j.canlet.2004.03.030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
673 Leong SM, Tan BX, Bte Ahmad B, Yan T, Chee LY, Ang ST, Tay KG, Koh LP, Yeoh AE, Koay ES, Mok YK, Lim TM. Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition. Blood 2010;116:3286-96. [PMID: 20606168 DOI: 10.1182/blood-2009-12-256149] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
674 Jennings MT, Iyengar S. The Molecular Genetics of Therapeutic Resistance in Malignant Astrocytomas: . American Journal of PharmacoGenomics 2001;1:93-9. [DOI: 10.2165/00129785-200101020-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
675 Kawada Y, Nakamura M, Ishida E, Shimada K, Oosterwijk E, Uemura H, Hirao Y, Chul KS, Konishi N. Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas. Jpn J Cancer Res 2001;92:1293-9. [PMID: 11749694 DOI: 10.1111/j.1349-7006.2001.tb02152.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
676 Rivard N, L'Allemain G, Bartek J, Pouysségur J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem 1996;271:18337-41. [PMID: 8702474 DOI: 10.1074/jbc.271.31.18337] [Cited by in Crossref: 155] [Cited by in F6Publishing: 158] [Article Influence: 6.0] [Reference Citation Analysis]
677 Lu H, Chang DJ, Baratte B, Meijer L, Schulze-Gahmen U. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin. J Med Chem 2005;48:737-43. [PMID: 15689157 DOI: 10.1021/jm049353p] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
678 Aprelikova O, Xiong Y, Liu ET. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem 1995;270:18195-7. [PMID: 7629134 DOI: 10.1074/jbc.270.31.18195] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 4.7] [Reference Citation Analysis]
679 Yue H, Yu JP, Cao YH, Zhao X. Expression of p57kip2 and p27kip1 proteins and its relationship with clinicopathology in human pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 318-320 [DOI: 10.11569/wcjd.v11.i3.318] [Reference Citation Analysis]
680 Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284. [PMID: 11291057 DOI: 10.1002/ijc.1174] [Cited by in Crossref: 699] [Cited by in F6Publishing: 618] [Article Influence: 33.3] [Reference Citation Analysis]
681 He XH, Li JJ, Xie YH, Tang YT, Yao GF, Qin WX, Wan DF, Gu JR. Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120. Cell Res 2004;14:487-96. [PMID: 15625016 DOI: 10.1038/sj.cr.7290252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
682 Niederacher D, Yan HY, An HX, Bender HG, Beckmann MW. CDKN2A gene inactivation in epithelial sporadic ovarian cancer. Br J Cancer. 1999;80:1920-1926. [PMID: 10471040 DOI: 10.1038/sj.bjc.6690621] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
683 Moschos SJ, Konstantinopoulos PA, Kirkwood JM. Melanoma. Elsevier; 2005. pp. 563-90. [DOI: 10.1016/s0921-4410(04)22025-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
684 Watanabe H, Fukuchi K, Takagi Y, Tomoyasu S, Tsuruoka N, Gomi K. Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1995;1263:275-80. [DOI: 10.1016/0167-4781(95)00110-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
685 Ruiz A, Puig S, Lynch M, Castel T, Estivill X. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma. Int J Cancer 1998;76:312-6. [PMID: 9579564 DOI: 10.1002/(sici)1097-0215(19980504)76:3<312::aid-ijc4>3.0.co;2-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
686 Seltenhammer MH, Heere-ress E, Brandt S, Druml T, Jansen B, Pehamberger H, Niebauer GW. Comparative Histopathology of Grey-Horse-Melanoma and Human Malignant Melanoma. Pigment Cell Res 2004;17:674-81. [DOI: 10.1111/j.1600-0749.2004.00192.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
687 Indsto JO, Holland EA, Kefford RF, Mann GJ. 10q deletions in metastatic cutaneous melanoma. Cancer Genet Cytogenet 1998;100:68-71. [PMID: 9406584 DOI: 10.1016/s0165-4608(97)00016-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
688 Reeder JE, O’connell MJ, Yang Z, Morreale JF, Collins L, Frank IN, Messing EM, Cockett AT, Cox C, Robinson RD, Wheeless LL. DNA cytometry and chromosome 9 aberrations by fluorescence in situ hybridization of irrigation specimens from bladder cancer patients. Urology 1998;51:58-61. [DOI: 10.1016/s0090-4295(98)00067-3] [Cited by in Crossref: 16] [Article Influence: 0.7] [Reference Citation Analysis]
689 Solomon DA, Kim JS, Ressom HW, Sibenaller Z, Ryken T, Jean W, Bigner D, Yan H, Waldman T. Sample type bias in the analysis of cancer genomes. Cancer Res 2009;69:5630-3. [PMID: 19567670 DOI: 10.1158/0008-5472.CAN-09-1055] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
690 Adám Z, Adány R, Ladányi A, Tímár J, Balázs M. Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p. Clin Exp Metastasis 2000;18:295-302. [PMID: